{"title":"Biotechnology Books","description":"","products":[{"product_id":"microbial-biotechnology-9780198822813","title":"Microbial Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eWritten primarily for students embarking on an undergraduate bioscience degree, this primer will introduce students to topics at the forefront of the subject that are being applied to probe biological problems, or to address the most pressing issues facing society. These topics will include those that form the cornerstone of contemporary research, helping students to make the transition to active researcher.Students will acquire a solid understanding of the essentials of microbial biotechnology, its applications in agriculture, diagnostics and urban and artistic conservation, as well as the potential threats genetic modification may pose to public health, the environment and intellectual property.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1: The basic principles of a biotechnology process 2: Microbial growth 3: Microbial bio-production 4: Biotechnology and food and drink production 5: Environmental biotechnology 6: Application of synthetic biology to biotechnology 7: Diagnostics 8: Microbial biotechnology and agriculture 9: Using extremophiles in biotechnology 10: Microbial biotechnology in the art and built environment 11: Ethical considerations","brand":"Oxford University Press","offers":[{"title":"Default Title","offer_id":48732797337943,"sku":"9780198822813","price":23.74,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780198822813.jpg?v=1719998440"},{"product_id":"recreating-nature-science-technology-and-human-values-in-the-twentyfirst-century-9780817320294","title":"ReCreating Nature Science Technology and Human","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAddresses emerging biotechnologies with prodigious potential to benefit humankind but that are also fraught with ethical consequences. James Bradley guides discussions of the thorny issues resulting from the development of new biotechnologies. He also highlights the responsibilities of scientists to conduct research in an ethical manner.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e“Building further on his remarkable scholarly work, James Bradley once again observes and dissects modern science and modern life in ways that challenge any kind of reader: student, scholar, research scientist, and most especially political decision makers. His interdisciplinary approach to studying the implications of biotechnology is the most accessible and useful, yet profound, of any academic work in this vast field. With characteristic good humor and patience, he confronts the fundamental issues within not only life sciences but moral and political philosophy as well. This is a necessary, although uncomfortable, wake-up call for humankind generally.\" - Timothy P. Terrel, Emory University School of Law and author of \u003ci\u003eThe Dimensions of Legal Reasoning: Developing Analytical Acuity from Law School to Law Practice\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAbbreviations and Acronyms\u003c\/li\u003e\n\u003cli\u003ePreface\u003c\/li\u003e\n\u003cli\u003eAcknowledgments\u003c\/li\u003e\n\u003cli\u003eChapter 1:   Cells, Molecules, Genes, and Nature\u003c\/li\u003e\n\u003cli\u003eChapter 2:   Embryos, Stem Cells, Genetic Enhancement, Genomics, and Synthetic Biology\u003c\/li\u003e\n\u003cli\u003eChapter 3:   Genetically Engineered Organisms\u003c\/li\u003e\n\u003cli\u003eChapter 4:   CRISPR and Life's Future\u003c\/li\u003e\n\u003cli\u003eChapter 5:   Nanotechnology, Life, and Nanoethics\u003c\/li\u003e\n\u003cli\u003eChapter 6:   Brains, Minds, and Neuroethics\u003c\/li\u003e\n\u003cli\u003eChapter 7:   Robots and Roboethics\u003c\/li\u003e\n\u003cli\u003eChapter 8:   Responsibilities and Living Well with Modern Biotechnologies\u003c\/li\u003e\n\u003cli\u003eChapter 9:   The Urgency of Now\u003c\/li\u003e\n\u003cli\u003eAppendix 1: The Central Dogma of Biology, CRISPR, and Gene Drive\u003c\/li\u003e\n\u003cli\u003eAppendix 2: Tools for Neuroscience and Clinical Neurology\u003c\/li\u003e\n\u003cli\u003eAppendix 3: Sources of Scientific Information for Non-Scientists\u003c\/li\u003e\n\u003cli\u003eReferences\u003c\/li\u003e\n\u003cli\u003eIndex\u003c\/li\u003e\n\u003cli\u003e\u003cul\u003e\u003c\/ul\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"The University of Alabama Press","offers":[{"title":"Default Title","offer_id":48737459011927,"sku":"9780817320294","price":30.56,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780817320294.jpg?v=1723811219"},{"product_id":"career-opportunities-in-biotechnology-and-drug-development-9780879698805","title":"Career Opportunities in Biotechnology and Drug","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"Cold Spring Harbor Laboratory Press,U.S.","offers":[{"title":"Default Title","offer_id":48737797538135,"sku":"9780879698805","price":23.75,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780879698805.jpg?v=1723811471"},{"product_id":"practical-techniques-in-molecular-biotechnology-9781108486408","title":"Practical Techniques in Molecular Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003ePractical Techniques in Molecular Biotechnology intends to familiarise students with the basics of the well-known experiments of molecular biotechnology and related courses like chemical biotechnology and cell biology. The content of the book will be useful in strengthening the basic skills and help students to apply the concepts to real-world problems. This book emphasises important concepts like bioanalytical techniques, biochemical analysis of proteins, recombinant DNA, and protein technology etc. The text will help students to understand the theoretical aspects of the techniques and provide experience with hands-on techniques to demonstrate practical troubleshooting and data analysis.  The text is supported with diagrams, data, summaries for the quick recap and appendices with useful protocols and calculation methods.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface; Acknowledgements; 1. Introduction; 2. Molecular Biology; 3. Recombinant DNA and Protein Technology; 4. Biochemical Analysis of Proteins; 5. Bioanalytical Techniques; 6. Cell Culture and Tissue Engineering; 7. Antibody Technology; Appendix A. Useful Protocols; Appendix B. Practical Applications; Appendix C. Significant Figures and Scientific Notations; Appendix D. Statistical Parameters Used in the Biochemical Measurements.","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":48738309734743,"sku":"9781108486408","price":52.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781108486408.jpg?v=1723811913"},{"product_id":"bioceramics-and-biocomposites-9781119049340","title":"Bioceramics and Biocomposites","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eProvides comprehensive coverage of the research into and clinical uses of bioceramics and biocomposites\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDevelopments related to bioceramics and biocomposites appear to be one the most dynamic areas in the field of biomaterials, with multiple applications in tissue engineering and medical devices. This book covers the basic science and engineering of bioceramics and biocomposites for applications in dentistry and orthopedics, as well as the state-of-the-art aspects of biofabrication techniques, tissue engineering, remodeling, and regeneration of bone tissue. It also provides insight into the use of bionanomaterials to create new functionalities when interfaced with biological molecules or structures.\u003c\/p\u003e \u003cp\u003eFeaturing contributions from leading experts in the field, \u003ci\u003eBioceramics and Biocomposites: From Research to Use in Clinical Practice\u003c\/i\u003e offers complete coverage of everything from extending the concept of hemopoietic and stromal niches, to the evolution of biocera\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eChapter 1. Multi-functionalized ferri-liposomes for hyperthermia induced glioma targeting and brain drug delivery\u003cbr\u003e\u003ci\u003eDi Shi, Gujie Mi, and Thomas J Webste\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 2. Biofabrication techniques for ceramics and composite bone scaffolds\u003cbr\u003e\u003ci\u003eFengyuan Liu, Boyang Huang, Sri Hinduja, Paulo Jorge da Silva Bartolo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 3. Developments in hydrogel-based scaffolds and bioceramics for bone regeneration\u003cbr\u003e\u003ci\u003eIzabela-Cristina Stancu, Daniel Chappard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 4. Zirconia-based composites for biomedical applications\u003cbr\u003e\u003ci\u003ePaula Palmero\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 5. Bioceramics derived from marble and sea shells as potential bone substitution materials\u003cbr\u003e\u003ci\u003eMiculescu Florin, Mocanu Aura Cătălina, Stan GE, Maidaniuc Andreea, Miculescu Marian, Voicu Stefan Ioan, Antoniac Iulian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 6. Bioglasses and glass-ceramics in the Na2O-CaO-MgO-SiO2-P2O5-CaF2 system\u003cbr\u003e\u003ci\u003eS. Agathopoulos and D.U. Tulyaganov\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 7. Electrical functionalization and fabrication of nanostructured hydroxyapatite coatings\u003cbr\u003e\u003ci\u003eVladimir Bystrov, Anna Bystrova, Yuri Dekhtyar, Igor Khlusov, Vladimir Pichugin, Konstantin Prosolov, Yurii Sharkeev\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 8. Bioactive microarc calcium phosphate coatings on nanostructured and ultrafine-grained bioinert metals and alloys\u003cbr\u003e\u003ci\u003eYurii Sharkeev, Ekaterina Komarova, Maria Sedelnikova, Igor Khlusov, Anna Eroshenko, Larisa Litvinova, Valeria Shupletsova\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 9. Engineering of bioceramics- based scaffold and its clinical applications in dentistry\u003cbr\u003e\u003ci\u003eIka Dewi Ana\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 10. Bioceramics in endodontics\u003cbr\u003e\u003ci\u003eAlexandru Andrei Iliescu, Paula Perlea, Gabriel Tulus, Mihaela Georgiana Iliescu, Irina Maria Gheorghiu, Horia Octavian Manolea\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 11. Extending the concept of hemopoietic and stromal niches as an approach to regenerative medicine\u003cbr\u003e\u003ci\u003eIgor A. Khlusov and Marina Yu. Khlusova\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 12. Experimental and pilot clinical study of different tissue-engineered bone grafts based on calcium phosphate, mesenchymal stem cells and adipose-derived stromal vascular fraction\u003cbr\u003e\u003ci\u003eI.Y. Bozo, G.A. Volozhin, V.L. Zorin, R.V. Deev, S.I. Rozhkov, P.S. Eremin, E.N. Toropov, A.A. Pulin, B.I. Grachev, I.I. Eremin, V.S. Komlev\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChapter 13. Bone substitutes in orthopedic and trauma surgery\u003cbr\u003e\u003ci\u003eLupescu Olivera, Antoniac Iulian\u003c\/i\u003e\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48738355937623,"sku":"9781119049340","price":143.06,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119049340.jpg?v=1723811968"},{"product_id":"engineering-and-technology-for-healthcare-9781119644248","title":"Engineering and Technology for Healthcare","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eInnovation in healthcare is currently a hot topic. Innovation allows us to think differently, to take risks and to develop ideas that are far better than existing solutions. Currently, there is no single book that covers all topics related to microelectronics, sensors, data, system integration and healthcare technology assessment in one reference. This book aims to critically evaluate current state-of-the-art technologies and provide readers with insights into developing new solutions. With contributions from a fully international team of experts across electrical engineering and biomedical fields, the book discusses how advances in sensing technology, computer science, communications systems and proteomics\/genomics are influencing healthcare technology today.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of Contributors xiii\u003c\/p\u003e \u003cp\u003eIntroduction xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Maximizing the Value of Engineering and Technology Research in Healthcare: Development-Focused Health Technology Assessment \u003c\/b\u003e\u003cb\u003e1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJanet Boutell Hawkins and Eleanor Grieve\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 1\u003c\/p\u003e \u003cp\u003e1.2 What Is HTA? 3\u003c\/p\u003e \u003cp\u003e1.3 What Is Development-Focused HTA? 4\u003c\/p\u003e \u003cp\u003e1.4 Illustration of Features of Development-Focused HTA 5\u003c\/p\u003e \u003cp\u003e1.4.1 Use-Focused HTA 6\u003c\/p\u003e \u003cp\u003e1.4.2 Development-Focused HTA 6\u003c\/p\u003e \u003cp\u003e1.5 Activities of Development-Focused HTA 7\u003c\/p\u003e \u003cp\u003e1.6 Analytical Methods of Development-Focused HTA 9\u003c\/p\u003e \u003cp\u003e1.6.1 Clinical Value Assessment 11\u003c\/p\u003e \u003cp\u003e1.6.2 Economic Value Assessment 11\u003c\/p\u003e \u003cp\u003e1.6.3 Evidence Generation 14\u003c\/p\u003e \u003cp\u003e1.7 What Are the Challenges in the Development and Assessment of Medical Devices? 15\u003c\/p\u003e \u003cp\u003e1.7.1 What Are Medical Devices? 15\u003c\/p\u003e \u003cp\u003e1.7.2 Challenges Common to All medical Devices 16\u003c\/p\u003e \u003cp\u003e1.7.2.1 Licensing and Regulation 16\u003c\/p\u003e \u003cp\u003e1.7.2.2 Adoption 17\u003c\/p\u003e \u003cp\u003e1.7.2.3 Evidence 18\u003c\/p\u003e \u003cp\u003e1.7.3 Challenges Specific to Some Categories of Device 19\u003c\/p\u003e \u003cp\u003e1.7.3.1 Learning Curve 19\u003c\/p\u003e \u003cp\u003e1.7.3.2 Short Lifespan and Incremental Improvement 19\u003c\/p\u003e \u003cp\u003e1.7.3.3 Workflow 19\u003c\/p\u003e \u003cp\u003e1.7.3.4 Indirect Health Benefit 19\u003c\/p\u003e \u003cp\u003e1.7.3.5 Behavioral and Other Contextual Factors 20\u003c\/p\u003e \u003cp\u003e1.7.3.6 Budgetary Challenges 20\u003c\/p\u003e \u003cp\u003e1.8 The Contribution of DF-HTA in the Development and Translation of Medical Devices 20\u003c\/p\u003e \u003cp\u003e1.8.1 Case Study 1 - Identifying and Confirming Needs 21\u003c\/p\u003e \u003cp\u003e1.8.2 Case Study 2 - What Difference Could This Device Make? 21\u003c\/p\u003e \u003cp\u003e1.8.3 Case Study 3 - Which Research Project Has the Most Potential? 21\u003c\/p\u003e \u003cp\u003e1.8.4 Case Study 4 - What Is the Required Performance to Deliver Clinical Utility? 21\u003c\/p\u003e \u003cp\u003e1.8.5 Case Study 5 - What Are the Key Parameters for Evidence Generation? 22\u003c\/p\u003e \u003cp\u003e1.9 Conclusion 22\u003c\/p\u003e \u003cp\u003eReferences 23\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Contactless Radar Sensing for Health Monitoring \u003c\/b\u003e\u003cb\u003e29\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFrancesco Fioranelli and Julien Le Kernec\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction: Healthcare Provision and Radar Technology 29\u003c\/p\u003e \u003cp\u003e2.2 Radar and Radar Data Fundamentals 32\u003c\/p\u003e \u003cp\u003e2.2.1 Principles of Radar Systems 32\u003c\/p\u003e \u003cp\u003e2.2.2 Principles of Radar Signal Processing for Health Applications 35\u003c\/p\u003e \u003cp\u003e2.2.3 Principles of Machine Learning Applied to Radar Data 38\u003c\/p\u003e \u003cp\u003e2.2.4 Complementary Approaches: Passive Radar and Channel State Information Sensing 41\u003c\/p\u003e \u003cp\u003e2.3 Radar Technology in Use for Health Care 42\u003c\/p\u003e \u003cp\u003e2.3.1 Activities Recognition and Fall Detection 42\u003c\/p\u003e \u003cp\u003e2.3.2 Gait Monitoring 46\u003c\/p\u003e \u003cp\u003e2.3.3 Vital Signs and Sleep Monitoring 48\u003c\/p\u003e \u003cp\u003e2.4 Conclusion and Outstanding Challenges 50\u003c\/p\u003e \u003cp\u003e2.5 Future Trends 52\u003c\/p\u003e \u003cp\u003e2.5.1 Paradigm Change in Radar Sensing 52\u003c\/p\u003e \u003cp\u003e2.5.2 Multimodal Sensing 55\u003c\/p\u003e \u003cp\u003eReferences 55\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Pervasive Sensing: Macro to Nanoscale \u003c\/b\u003e\u003cb\u003e61\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eQammer H. Abbasi, Hasan T. Abbas, Muhammad Ali Imran and Akram Alomainy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 61\u003c\/p\u003e \u003cp\u003e3.2 The Anatomy of a Human Skin 64\u003c\/p\u003e \u003cp\u003e3.3 Characterization of Human Tissue 65\u003c\/p\u003e \u003cp\u003e3.4 Tissue Sample Preparation 70\u003c\/p\u003e \u003cp\u003e3.5 Measurement Apparatus 70\u003c\/p\u003e \u003cp\u003e3.6 Simulating the Human Skin 72\u003c\/p\u003e \u003cp\u003e3.6.1 Human Body Channel Modelling 73\u003c\/p\u003e \u003cp\u003e3.7 Networking and Communication Mechanisms for Body-Centric Wireless Nano-Networks 76\u003c\/p\u003e \u003cp\u003e3.8 Concluding Remarks 78\u003c\/p\u003e \u003cp\u003eReferences 78\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Biointegrated Implantable Brain Devices \u003c\/b\u003e\u003cb\u003e81\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRupam Das and Hadi Heidari\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Background 81\u003c\/p\u003e \u003cp\u003e4.2 Neural Device Interfaces 83\u003c\/p\u003e \u003cp\u003e4.3 Implant Tissue Biointegration 84\u003c\/p\u003e \u003cp\u003e4.4 MRI Compatibility of the Neural Devices 87\u003c\/p\u003e \u003cp\u003e4.5 Conclusion 90\u003c\/p\u003e \u003cp\u003eReferences 90\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Machine Learning for Decision Making in Healthcare \u003c\/b\u003e\u003cb\u003e95\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAli Rizwan, Metin Ozturk, Najah Abu Ali, Ahmed Zoha, Qammer H. Abbasi and M. Ali Imran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 95\u003c\/p\u003e \u003cp\u003e5.2 Data Description 98\u003c\/p\u003e \u003cp\u003e5.3 Proposed Methodology 99\u003c\/p\u003e \u003cp\u003e5.3.1 Collection of the Data 99\u003c\/p\u003e \u003cp\u003e5.3.2 Selection of the Window Size 100\u003c\/p\u003e \u003cp\u003e5.3.3 Extraction of the Features 101\u003c\/p\u003e \u003cp\u003e5.3.4 Selection of the Features 101\u003c\/p\u003e \u003cp\u003e5.3.5 Deployment of the Machine Learning Models 102\u003c\/p\u003e \u003cp\u003e5.3.6 Quantitative Assessment of the Models 103\u003c\/p\u003e \u003cp\u003e5.3.7 Parallel Processing 104\u003c\/p\u003e \u003cp\u003e5.4 Results 105\u003c\/p\u003e \u003cp\u003e5.5 Analysis and Discussion 108\u003c\/p\u003e \u003cp\u003e5.5.1 Postures 108\u003c\/p\u003e \u003cp\u003e5.5.2 Window Sizes 109\u003c\/p\u003e \u003cp\u003e5.5.3 Feature Combinations 109\u003c\/p\u003e \u003cp\u003e5.5.4 Machine Learning Algorithms 111\u003c\/p\u003e \u003cp\u003e5.6 Conclusions 113\u003c\/p\u003e \u003cp\u003eReferences 113\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Information Retrieval from Electronic Health Records \u003c\/b\u003e\u003cb\u003e117\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMeshal Al-Qahtani, Stamos Katsigiannis and Naeem Ramzan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 117\u003c\/p\u003e \u003cp\u003e6.2 Methodology 118\u003c\/p\u003e \u003cp\u003e6.2.1 Parallel LSI (PLSI) 119\u003c\/p\u003e \u003cp\u003e6.2.2 Distributed LSI (DLSI) 121\u003c\/p\u003e \u003cp\u003e6.3 Results and Analysis 122\u003c\/p\u003e \u003cp\u003e6.4 Conclusion 126\u003c\/p\u003e \u003cp\u003eReferences 126\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Energy Harvesting for Wearable and Portable Devices \u003c\/b\u003e\u003cb\u003e129\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRami Ghannam, You Hao, Yuchi Liu and Yidi Xiao\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 129\u003c\/p\u003e \u003cp\u003e7.2 Energy Harvesting Techniques 130\u003c\/p\u003e \u003cp\u003e7.2.1 Photovoltaics 130\u003c\/p\u003e \u003cp\u003e7.2.2 Piezoelectric Energy Harvesting 134\u003c\/p\u003e \u003cp\u003e7.2.3 Thermal Energy Harvesting 137\u003c\/p\u003e \u003cp\u003e7.2.3.1 Latest Trends 139\u003c\/p\u003e \u003cp\u003e7.2.4 RF Energy Harvesting 141\u003c\/p\u003e \u003cp\u003e7.3 Conclusions 145\u003c\/p\u003e \u003cp\u003eReferences 146\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Wireless Control for Life-Critical Actions \u003c\/b\u003e\u003cb\u003e153\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBurak Kizilkaya, Bo Chang, Guodong Zhao and Muhammad Ali Imran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 153\u003c\/p\u003e \u003cp\u003e8.2 Wireless Control for Healthcare 155\u003c\/p\u003e \u003cp\u003e8.3 Technical Requirements 156\u003c\/p\u003e \u003cp\u003e8.3.1 Ultra-Reliability 156\u003c\/p\u003e \u003cp\u003e8.3.2 Low Latency 156\u003c\/p\u003e \u003cp\u003e8.3.3 Security and Privacy 157\u003c\/p\u003e \u003cp\u003e8.3.4 Edge Artificial Intelligence 157\u003c\/p\u003e \u003cp\u003e8.4 Design Aspects 157\u003c\/p\u003e \u003cp\u003e8.4.1 Independent Design 158\u003c\/p\u003e \u003cp\u003e8.4.2 Co-Design 159\u003c\/p\u003e \u003cp\u003e8.5 Co-Design System Model 159\u003c\/p\u003e \u003cp\u003e8.5.1 Control Function 159\u003c\/p\u003e \u003cp\u003e8.5.2 Performance Evaluation Criterion 161\u003c\/p\u003e \u003cp\u003e8.5.2.1 Control Performance 161\u003c\/p\u003e \u003cp\u003e8.5.2.2 Communication Performance 161\u003c\/p\u003e \u003cp\u003e8.5.3 Effects of Different QoS 162\u003c\/p\u003e \u003cp\u003e8.5.4 Numerical Results 163\u003c\/p\u003e \u003cp\u003e8.6 Conclusions 165\u003c\/p\u003e \u003cp\u003eReferences 165\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Role of D2D Communications in Mobile Health Applications: Security Threats and Requirements \u003c\/b\u003e\u003cb\u003e169\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMuhammad Usman, Marwa Qaraqe, Muhammad Rizwan Asghar and Imran Shafique Ansari\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 169\u003c\/p\u003e \u003cp\u003e9.2 D2D Scenarios for Mobile Health Applications 170\u003c\/p\u003e \u003cp\u003e9.3 D2D Security Requirements and Standardization 171\u003c\/p\u003e \u003cp\u003e9.3.1 Security Issues on Configuration 171\u003c\/p\u003e \u003cp\u003e9.3.1.1 Configuration of the ProSe Enabled UE 171\u003c\/p\u003e \u003cp\u003e9.3.2 Security Issues on Device Discovery 172\u003c\/p\u003e \u003cp\u003e9.3.2.1 Direct Request and Response Discovery 172\u003c\/p\u003e \u003cp\u003e9.3.2.2 Open Direct Discovery 173\u003c\/p\u003e \u003cp\u003e9.3.2.3 Restricted Direct Discovery 173\u003c\/p\u003e \u003cp\u003e9.3.2.4 Registration in Network-Based ProSe Discovery 173\u003c\/p\u003e \u003cp\u003e9.3.3 Security Issues on One-to-Many Communications 174\u003c\/p\u003e \u003cp\u003e9.3.3.1 One-to-many communications between UEs 174\u003c\/p\u003e \u003cp\u003e9.3.3.2 Key Distribution for Group Communications 174\u003c\/p\u003e \u003cp\u003e9.3.4 Security Issues on One-to-One Communication 175\u003c\/p\u003e \u003cp\u003e9.3.4.1 One-to-One ProSe Direct Communication 175\u003c\/p\u003e \u003cp\u003e9.3.4.2 One-to-One ProSe Direct Communication 175\u003c\/p\u003e \u003cp\u003e9.3.5 Security Issues on ProSe Relays 175\u003c\/p\u003e \u003cp\u003e9.3.5.1 Maintaining 3GPP Communication Security through Relay 175\u003c\/p\u003e \u003cp\u003e9.3.5.2 UE-Network Relay 176\u003c\/p\u003e \u003cp\u003e9.3.5.3 UE-to-UE Relay 176\u003c\/p\u003e \u003cp\u003e9.4 Existing Solutions 176\u003c\/p\u003e \u003cp\u003e9.4.1 Key Management 176\u003c\/p\u003e \u003cp\u003e9.4.2 Routing 178\u003c\/p\u003e \u003cp\u003e9.4.3 Social Trust and Social Ties 178\u003c\/p\u003e \u003cp\u003e9.4.4 Access Control 180\u003c\/p\u003e \u003cp\u003e9.4.5 Physical Layer Security 180\u003c\/p\u003e \u003cp\u003e9.4.6 Network Coding 183\u003c\/p\u003e \u003cp\u003e9.5 Conclusion 183\u003c\/p\u003e \u003cp\u003eReferences 183\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Automated Diagnosis of Skin Cancer for Healthcare: Highlights and Procedures \u003c\/b\u003e\u003cb\u003e187\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMaram A. Wahba and Amira S. Ashour\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 187\u003c\/p\u003e \u003cp\u003e10.2 Framework of Computer-Aided Skin Cancer Classification Systems 188\u003c\/p\u003e \u003cp\u003e10.2.1 Image Acquisition 188\u003c\/p\u003e \u003cp\u003e10.2.2 Image Pre-Processing 189\u003c\/p\u003e \u003cp\u003e10.2.2.1 Color Contrast Enhancement 189\u003c\/p\u003e \u003cp\u003e10.2.2.2 Artifact Removal 190\u003c\/p\u003e \u003cp\u003e10.2.3 Image Segmentation 191\u003c\/p\u003e \u003cp\u003e10.2.3.1 Thresholding-Based Segmentation 192\u003c\/p\u003e \u003cp\u003e10.2.3.2 Edge-Based Segmentation 192\u003c\/p\u003e \u003cp\u003e10.2.3.3 Region-Based Segmentation 193\u003c\/p\u003e \u003cp\u003e10.2.3.4 Active Contours-Based Segmentation 193\u003c\/p\u003e \u003cp\u003e10.2.3.5 Artificial Intelligence-Based Segmentation 194\u003c\/p\u003e \u003cp\u003e10.2.4 Feature Extraction 195\u003c\/p\u003e \u003cp\u003e10.2.4.1 Color-based Features 196\u003c\/p\u003e \u003cp\u003e10.2.4.2 Dimensional Features 196\u003c\/p\u003e \u003cp\u003e10.2.4.3 Texture-Based Features 196\u003c\/p\u003e \u003cp\u003e10.2.4.4 Dermoscopic Rules and Methods 197\u003c\/p\u003e \u003cp\u003e10.2.5 Feature Selection 200\u003c\/p\u003e \u003cp\u003e10.2.6 Classification 201\u003c\/p\u003e \u003cp\u003e10.2.7 Classification Performance Evaluation 202\u003c\/p\u003e \u003cp\u003e10.2.8 Computer-Aided Diagnosis Systems in Dermoscopic Images 203\u003c\/p\u003e \u003cp\u003e10.3 Conclusion 205\u003c\/p\u003e \u003cp\u003eAcknowledgment 205\u003c\/p\u003e \u003cp\u003eReferences 205\u003c\/p\u003e \u003cp\u003eConclusions 213\u003c\/p\u003e \u003cp\u003eIndex 215\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48738363310423,"sku":"9781119644248","price":89.96,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119644248.jpg?v=1723811976"},{"product_id":"inside-the-orphan-drug-revolution-the-promise-of-patient-centered-biotechnology-9781621824688","title":"Inside the Orphan Drug Revolution: The Promise of","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"Cold Spring Harbor Laboratory Press,U.S.","offers":[{"title":"Default Title","offer_id":48740661789015,"sku":"9781621824688","price":20.9,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781621824688.jpg?v=1723812316"},{"product_id":"biotechnology-science-for-the-new-millennium-9781639890811","title":"Biotechnology: Science for the New Millennium","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"States Academic Press","offers":[{"title":"Default Title","offer_id":48740760813911,"sku":"9781639890811","price":118.58,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781639890811.jpg?v=1720055553"},{"product_id":"biocatalysis-in-organic-synthesis-the-retrosynthesis-approach-9781782625308","title":"Biocatalysis in Organic Synthesis: The","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe application of biocatalysis in organic synthesis is rapidly gaining popularity amongst chemists. Compared to traditional synthetic methodologies biocatalysis offers a number of advantages in terms of enhanced selectivity (chemo-, regio-, stereo-), reduced environmental impact and lower cost of starting materials. Together these advantages can contribute to more sustainable manufacturing processes across a wide range of industries ranging from pharmaceuticals to biofuels. The biocatalytic toolbox has expanded significantly in the past five years and given the current rate of development of new engineered biocatalysts it is likely that the number of available biocatalysts will double in the next few years.  This textbook gives a comprehensive overview of the current biocatalytic toolbox and also establishes new guidelines or rules for “biocatalytic retrosynthesis”. Retrosynthesis is a well known and commonly used technique whereby organic chemists start with the structure of their target molecule and generate potential starting materials and intermediates through a series of retrosynthetic disconnections. These disconnections are then used to devise a forward synthesis, in this case using biocatalytic transformations in some of the key steps. Target molecules are disconnected with consideration for applying biocatalysts, as well as chemical reagents and chemocatalysts, in the forward synthesis direction. Using this textbook, students will be able to place biocatalysis within the context of other synthetic transformations that they have learned earlier in their studies. This additional awareness of biocatalysis will equip students for the modern world of organic synthesis where biocatalysts play an increasingly important role. In addition to guidelines for identifying where biocatalysts can be applied in organic synthesis, this textbook also provides examples of current applications of biocatalysis using worked examples and case studies. Tutorials enable the reader to practice disconnecting target molecules to find the ‘hidden’ biocatalytic reactions which can be applied in the synthetic direction. The book contains a complete description of the current biocatalyst classes that are available for use and also suggests areas where new enzymes are likely to be developed in the next few years. This textbook is an essential resource for lecturers and students studying synthetic organic chemistry. It also serves as a handy reference for practicing chemists who wish to embed biocatalysis into their synthetic toolbox.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eIntroduction and Aims of the Book; Biocatalysis Basics and Principles; Hydrolysis; Reverse Hydrolysis: Reduction; Oxidation; C–X Bond Formation; C–C Bond Formation, Miscellaneous Biocatalysts; Biocatalytic Disconnections and Functional Group Interconversions; Comparison of Different Biocatalytic Routes to Target Molecules; Applications of Biocatalytic Retrosynthesis","brand":"Royal Society of Chemistry","offers":[{"title":"Default Title","offer_id":48741113921879,"sku":"9781782625308","price":47.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781782625308.jpg?v=1720056617"},{"product_id":"genomics-wired-guides-how-genome-sequencing-will-change-our-lives-9781847943408","title":"Genomics (WIRED guides): How Genome Sequencing","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eGenome sequencing is one of the most exciting scientific breakthroughs of the past thirty years. But what precisely does it involve and how is it developing?\u003cbr\u003e\u003cbr\u003e In this brilliantly wide-ranging, one-stop guide WIRED journalist Rachael Pells explains the science behind genomics. She analyses its practical applications in medical diagnosis and the treatment of conditions that range from cancer to severe allergic reactions to cystic fibrosis. She considers its potential to help with advances in agriculture and environmental science. She explores the ethics of genetic modification and the dangers involved when humans 'play God'. And she addresses the fundamental question: to what extent will future advances transform human longevity and the quality of life.\u003c\/p\u003e","brand":"Cornerstone","offers":[{"title":"Default Title","offer_id":48742230884695,"sku":"9781847943408","price":8.54,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781847943408.jpg?v=1720060559"},{"product_id":"essential-current-concepts-in-stem-cell-biology-9783030339227","title":"Essential Current Concepts in Stem Cell Biology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis textbook describes the biology of different adult stem cell types and outlines the current level of knowledge in the field. It clearly explains the basics of hematopoietic, mesenchymal and cord blood stem cells and also covers induced pluripotent stem cells. Further, it includes a chapter on ethical aspects of human stem cell research, which promotes critical thinking and responsible handling of the material.\u003c\/p\u003e\u003cp\u003eBased on the international masters program Molecular and Developmental Stem Cell Biology taught at Ruhr-University Bochum and Tongji University Shanghai, the book is a valuable source for postdocs and researchers working with stems cells and also offers essential insights for physicians and dentists wishing to expand their knowledge.\u003c\/p\u003e\u003cp\u003eThis textbook is a valuable complement to \u003ci\u003eConcepts and Applications of Stem Cell Biology, \u003c\/i\u003ealso published in the Learning Materials in Biosciences textbook series.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e“The books ... ‘compactly and concisely discuss a specific bio-topic based on lectures for upper-level undergraduates, master’s and graduate students’: this means that both beginners and well-trained students can benefit from reading this and other books in the same collection. ... All chapters are decorated by clear and well-designed color illustrations. I am pretty sure the book will meet the reader’s expectations.” (Manuela Monti, European Journal of Histochemistry, Vol. 64, 2020)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1. Hematopoietic stem cells\u003cp\u003e2. Mesenchymal stem cells \u003c\/p\u003e  \u003cp\u003e3. Cord blood stem cells  \u003c\/p\u003e  \u003cp\u003e4. Induced pluripotent stem cells \u003c\/p\u003e  \u003cp\u003e5. Epigenetic regulation in somatic cell reprogramming \u003c\/p\u003e  \u003cp\u003e6. MET in reprogramming \u003c\/p\u003e  \u003cp\u003e7. Extracellular vesicles      \u003c\/p\u003e  \u003cp\u003e8. Neural stem cells   \u003c\/p\u003e  \u003cp\u003e9. Neural stem cell niche\u003c\/p\u003e  \u003cp\u003e10. Human pluripotent stem cells and neural regeneration                                                                 \u003c\/p\u003e  \u003cp\u003e11. Organoids \u003c\/p\u003e  \u003cp\u003e12. Ethical aspects of human stem cell research                       \u003c\/p\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743033504087,"sku":"9783030339227","price":59.99,"currency_code":"GBP","in_stock":true}]},{"product_id":"introduction-to-antibody-engineering-9783030546298","title":"Introduction to Antibody Engineering","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis highly readable textbook serves as a concise and engaging primer to the emerging field of antibody engineering and its various applications. It introduces readers to the basic science and molecular structure of antibodies, and explores how to characterize and engineer them. Readers will find an overview of the latest methods in antibody identification, improvement and biochemical engineering. Furthermore, alternative antibody formats and bispecific antibodies are discussed.\u003c\/p\u003e\u003cp\u003eThe book’s content is based on lectures for the specializations “Protein Engineering” and “Medical Biotechnology” within the Master’s curriculum in “Biotechnology.” The lectures have been held at the University of Natural Resources and Life Sciences, Vienna, in cooperation with the Medical University of Vienna, since 2012 and are continuously adapted to reflect the latest developments in the field.\u003c\/p\u003e\u003cp\u003e The book addresses Master- and PhD students in biotechnology, molecular biology and immunology, and all those who are interested in antibody engineering.\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743040123223,"sku":"9783030546298","price":63.06,"currency_code":"GBP","in_stock":true}]},{"product_id":"a-practical-guide-to-protein-engineering-9783030568979","title":"A Practical Guide to Protein Engineering","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis textbook introduces readers in an accessible and engaging way to the nuts and bolts of protein expression and engineering. Various case studies illustrate each step from the early sequence searches in online databases over plasmid design and molecular cloning techniques to protein purification and characterization. Furthermore, readers are provided with practical tips to successfully pursue a career as a protein engineer. With protein engineering being a fundamental technique in almost all molecular biology labs, the book targets advanced undergraduates and graduate students working in molecular biology, biotechnology and related scientific fields.\u003c\/p\u003e  \u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePart I: Chapter 1: A brief history of protein engineeringChapter 2: From DNA to functional protein – A refresherChapter 3: Basic laboratory and computational techniques\u003cbr\u003ePart II:Chapter 4: Protein engineering strategiesChapter 5: Computational tools for protein engineeringChapter 6: Gene isolationChapter 7: Rational design Chapter 8: Directed evolutionChapter 9: Protein modification\u003cbr\u003ePart III:Chapter 10: Career prospect of a protein engineerChapter 11: Conversations with protein engineers\u003cbr\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743040713047,"sku":"9783030568979","price":68.0,"currency_code":"GBP","in_stock":true}]},{"product_id":"rice-improvement-physiological-molecular-breeding-and-genetic-perspectives-9783030665326","title":"Rice Improvement: Physiological, Molecular","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book is open access under a CC BY 4.0 license.\u003cbr\u003eBy 2050, human population is expected to reach 9.7 billion. The demand for increased food production needs to be met from ever reducing resources of land, water and other environmental constraints. Rice remains the staple food source for a majority of the global populations, but especially in Asia where ninety percent of rice is grown and consumed. Climate change continues to impose abiotic and biotic stresses that curtail rice quality and yields. Researchers have been challenged to provide innovative solutions to maintain, or even increase, rice production. Amongst them, the ‘green super rice’ breeding strategy has been successful for leading the development and release of multiple abiotic and biotic stress tolerant rice varieties. Recent advances in plant molecular biology and biotechnologies have led to the identification of stress responsive genes and signaling pathways, which open up new paradigms to augment rice productivity. Accordingly, transcription factors, protein kinases and enzymes for generating protective metabolites and proteins all contribute to an intricate network of events that guard and maintain cellular integrity. In addition, various quantitative trait loci associated with elevated stress tolerance have been cloned, resulting in the detection of novel genes for biotic and abiotic stress resistance. Mechanistic understanding of the genetic basis of traits, such as N and P use, is allowing rice researchers to engineer nutrient-efficient rice varieties, which would result in higher yields with lower inputs. Likewise, the research in micronutrients biosynthesis opens doors to genetic engineering of metabolic pathways to enhance micronutrients production. With third generation sequencing techniques on the horizon, exciting progress can be expected to vastly improve molecular markers for gene-trait associations forecast with increasing accuracy. \u003cbr\u003eThis book emphasizes on the areas of rice science that attempt to overcome the foremost limitations in rice production. Our intention is to highlight research advances in the fields of physiology, molecular breeding and genetics, with a special focus on increasing productivity, improving biotic and abiotic stress tolerance and nutritional quality of rice.\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1\tAdvances in Genetics and Breeding of Rice: An Overview2\tStrategies for engineering photosynthesis for enhanced plant biomass production3\tGreen super rice (GSR) traits: Breeding and genetics for multiple biotic and abiotic stress tolerance in rice4\tAdvances in two-line heterosis breeding in rice via the temperature-sensitive genetic male sterility system5\tGrowing rice with less water: improving productivity by decreasing water demand6\tCrop establishment in direct-seeded rice: traits, physiology and genetics7\tGenetics and Breeding of Heat Tolerance in Rice8\tGenetics and Breeding of Low-temperature stress tolerance in rice 9\tArsenic stress responses and accumulation in rice10\tMolecular approaches for Disease Resistance in Rice11\tMolecular approaches for insect pest management in rice12\tDoubled Haploids in Rice improvement: Approaches, Applications and Future prospects13\tZinc-biofortified rice: a sustainable food-based product for fighting zinc malnutrition14\tBiofortification of Rice Grains for Increased Iron Content\u003cbr\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743044317527,"sku":"9783030665326","price":26.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783030665326.jpg?v=1720063866"},{"product_id":"multifaceted-protocols-in-biotechnology-volume-2-9783030755782","title":"Multifaceted Protocols in Biotechnology, Volume 2","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis contributed volume, “Multifaceted Protocols in Biotechnology, Volume 2”, consists of multidisciplinary methods and techniques commonly used in biotechnology studies. There are two sections covered in this book – Ionic Liquid Related Techniques \u0026amp; Evergreen Biotechnology Techniques. A brief introduction supports each protocol to allow easy learning and implementation. The first section consists of three chapters covering studies in modern biotechnology focusing on the role of ionic liquid techniques in extracting secondary metabolites, enzyme stabilization and biomass processing. The second section covers evergreen methodologies. It comprises five chapters covering topics on microcarrier technology for cell culture; Polymerase Chain Reaction for non-halal sources detection in food; ELISA for biomarker identification; gamma ray-induced mutagenesis for enhancing microbial fuel cells; and the effect of temperature on antibacterial activity of Carica papaya seed extract. This book will be useful to graduate students, researchers, academics, and industry practitioners working in the area of biotechnology\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eChapter 1Graviola Fruit Extraction by Ionic Liquid Microwave-assisted Extraction (IL-MAE) Daddiouaissa Djabir, and Azura Amid\u003cbr\u003eChapter 2Role of Ionic Liquids in the Enzyme Stabilization: A Case Study with Trichoderma ressie Cellulase Amal A. M. Elgharbawy, Md Zahangir Alam, and Muhammad Moniruzzaman\u003cbr\u003eChapter 3Role of Ionic Liquids in the Processing of Lignocellulosic BiomassAmal A. M. Elgharbawy, Md Zahangir Alam, Sharifah Shahira Syed Putra and Muhammad Moniruzzaman\u003cbr\u003eChapter 4Proliferation of rat amniotic stem cell (AFSC) on modified surface microcarrier.Nurhusna Samsudin, Yumi Zuhanis Has-Yun Hashim, Hamzah Mohd Salleh, and Azmir Ariffin.\u003cbr\u003eChapter 5Application of spectroscopic methods for the analysis of non-halal meats in food products: A narrative reviewAbdul Rohman, Nurrulhidayah Ahmad Fadzillah\u003cbr\u003eChapter 6Identification of Potential Biomarkers of Porcine GelatinNur Azira Tukiran, Amin Ismail, Haizatul Hadirah Ghazali \u0026amp; Nurul Azarima Mohd Ali\u003cbr\u003eChapter 7Gamma Ray Mutagenesis on Bacteria Isolated from Shrimp Farm Mud for Microbial Fuel Cell Enhancement and Degradation of Organic WasteAyoub Ahmed Ali, and Azura Amid, Azhar Muhammad\u003cbr\u003eChapter 8Effect of temperature on antibacterial activity and fatty acid methyl esters of Carica papaya seed extractMuhamad Shirwan Abdullah Sani, Jamilah Bakar, Russly Abdul Rahman and Faridah Abas\u003cbr\u003eChapter 9Solid-state Fermentation of Agro-industrial Waste Using Heterofermentative Lacti Acid Bacteria. Oktaviani, Muhammad Yusuf Abduh, Dea Indriani Astuti, Mia Rosmiati\u003cbr\u003eChapter 10Synthesis of chitosan-folic acid nanoparticles as a drug delivery system for propolis compounds Marselina Irasonia Tan and Adelina Khristiani Rahayu\u003cbr\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743048642903,"sku":"9783030755782","price":44.99,"currency_code":"GBP","in_stock":true}]},{"product_id":"informality-labour-mobility-and-precariousness-supplementing-the-state-for-the-invisible-and-the-vulnerable-9783030825010","title":"Informality, Labour Mobility and Precariousness:","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eFrom the erosion of state legitimacy in Lebanon to the use of smartphones in Kyrgyzstan, from a Polish suburb to the music scene in Azerbaijan, this volume attempts to explain why, in a variety of world regions, a substantial number of people tend to ignore or act against state rules. We propose to look at informality beyond simplistic associations of the phenomenon with a single category such as \"informal labour\" or \"corruption\". By doing this, we propose to look for a correlation between the emergence, and persistence, of some informal practices and the quality of governance in a given area. We also suggest that a better understanding of the variety of informal practices present in a region can help conceptualising more adequate interventions and eventually improve the socio-economic conditions of its inhabitants.  \u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePart I. Introduction. - Chapter 1. The (im)moralities of informality: states, their citizens and conflicting moral orders (Abel Polese). - Part II. Coming. - Chapter 2. (Im)mobilities and Informality as Livelihood Strategies in Transnational Social Fields (Ignacio Fradejas-García, José Molina and Miranda Lubbers). - Chapter 3. Restaurant Backyards, Food Stores, and Temples. Invisibility, informal labour Practices, and Migrant Networks in the Suburbs of Warsaw (Karolina Bielenin-Lenczowska and Helena Patzer). - Chapter 4. Informal Networks Among Immigrant Entrepreneurs: Case of Croatia (Ružica Šimić Banović, Vlatka Škokić, Mirela Alpeza). - Chapter 5. “Performance of Illegality” towards migrants living with HIV in Russia: from Social Exclusion to Deportation (Daniel Kashinitsky). - Part III. Staying. - Chapter 5. Institutions and the Informal Economy – Tax Morale of Small Businesses in Armenia and Georgia (Joanna Paquin). - Chapter 6. Left in the “Shadows”: the Informal Moral Economy of the Russian Far East (Aimar Ventsel). - Chapter 7. Azerbaijani Meykhana: Cultural Policy and Local Actors’ Agenda (Aneta Strzemżalska). - Chapter 8. Everyday forms of governance in Uzbekistan: the illegal, the immoral and the illegitimate (Abel Polese, Rustamjon Urinboyev, Mans Svensson, Laura Adams, Tanel Kerikmäe). - Part IV. Competing. - Chapter 9. Mixed Perceptions of State Responsibility among Informal Sector Participants (Anil Duman). - Chapter 10. State Collusion or Erosion During a Sovereign Debt Crisis: Market Dynamics Spawn Informal Practices in Lebanon (Joseph Helou). - Chapter 11. Perceived Pull and Push Factors of Healthcare Professionals Intention for Mobility: The Case Of Romania (Elena Druică and Rodica Ianole – Călin). - Chapter 12. E-nformality: Smartphones as a New Regulatory Space for Informal Exchange of Formal Resources (Aksana Ismailbekova and Gulzat Baialieva). - Chapter 13. Work, Subsistence and Distress of the Homeless in Moldova (Petru Negură)","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743052247383,"sku":"9783030825010","price":104.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783030825010.jpg?v=1720063900"},{"product_id":"fundamentals-of-rna-structure-and-function-9783030902131","title":"Fundamentals of RNA Structure and Function","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis highly illustrated textbook provides an essential overview on RNA architecture and function, it offers insights into the RNA basics and also explains novel RNA technologies, such as CRISPR-Cas and their applications. In addition, the mRNA based vaccine technology, which has long been tested, also before the COVID-19 pandemic, is discussed and students receive a basic understanding of this important medical application.\u003c\/p\u003e\u003cp\u003eThe textbook is written by Prof. Grover in collaboration with her students and has an easily accessible style.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003eThe book provides a great tool for young researchers and students in biology, biomedical engineering or biochemistry, looking for a compact introduction or refresher work on RNA, including the newest findings and technologies. It is an ideal starter to learn about several RNA specific topics and to research them further.\u003cb\u003e\u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e1. RNA-Composition and Base Pairing.- 2. Architecture of RNA.- 3. Small Catalytic RNA.- 4. The Spliceosome: A Large Catalytic RNA.- 5. A Genomic Perspective on RNA.- 6. The mRNA and the New Vaccines.- 7. Riboswitches: Sensors and Regulators.- 8. Small Non-Coding RNA, miRNA in Gene Regulation.- 9. CRISPR-Cas Systems, The science and ethics of gene manipulation.- 10. Transcription.\u003c\/p\u003e\u003cbr\u003e  \u003cp\u003e\u003c\/p\u003e            \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003c\/p\u003e    \u003cp\u003e\u003c\/p\u003e                \u003cp\u003e\u003c\/p\u003e","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743056998743,"sku":"9783030902131","price":58.11,"currency_code":"GBP","in_stock":true}]},{"product_id":"gender-and-migration-imiscoe-short-reader-9783030919702","title":"Gender and Migration: IMISCOE Short Reader","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis open access short reader offers a critical review of the debates on the transformation of migration and gendered mobilities primarily in Europe, though also engaging in wider theoretical insights. Building on empirical case studies and grounded in an analytical framework that incorporates both men and women, masculinities, sexualities and wider intersectional insights, this reader provides an accessible overview of conceptual developments and methodological shifts and their implications for a gendered understanding of migration in the past 30 years. It explores different and emerging approaches  in major areas, such as: gendered labour markets across diverse sectors beyond  domestic and care work to include skilled sectors of social reproduction; the significance of families in migration and transnational families; displacement, asylum and refugees and the incorporation of gender and sexuality in asylum determination; academic critiques and gendered discourses concerning integration often with the focus on Muslim women. The reader concludes with considerations of the potential impact of three notable developments on gendered migrations and mobilities: Black Lives Matter, Brexit and COVID-19. As such, it is a valuable resource for students, academics, policy makers, and practitioners.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eChapter 1: Gender and Migration: an Introduction.- Chapter 2: Gendered Migrations and Conceptual Approaches: Theorising and Researching Mobilities.- Chapter 3: Gendered Labour.- Chapter 4: Transnational Families, Intimate Relations, Generations.- Chapter 5: Gendering Asylum.- Chapter 6: Engendering Integration and Inclusion.- Chapter 7: Conclusion.","brand":"Springer Nature Switzerland AG","offers":[{"title":"Default Title","offer_id":48743058243927,"sku":"9783030919702","price":17.09,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783030919702.jpg?v=1720063927"},{"product_id":"novel-innovation-design-for-the-future-of-health-entrepreneurial-concepts-for-patient-empowerment-and-health-democratization-9783031081903","title":"Novel Innovation Design for the Future of Health:","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis book highlights the reasons for an urgently needed revision of the current global healthcare setup, discusses the needed mindset for a future of health, and provides a comprehensive development toolset for disruption (and for the needed incremental innovations towards disruption).\u003c\/p\u003e\u003cp\u003eToday’s biomedical and health innovation related research in universities encourages activities that lead to incremental innovations with a relatively low risk of failure. The healthcare industry on the other hand provides tools and devices for established healthcare providers to improve the diagnosis and therapy\/ treatment of the patients’ health problems. The patient is not in the center of healthcare provision however, and prevention and prediction are not core goals. The current health setup needs to be challenged and disrupted.\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eDisruptions are coming from technologies or processes that lead to a significant (\u0026gt;10x) reduction in cost or price\/ performance and that also come with new business models. The need for change, effects of exponential technologies, and the needed shift to prevention and to homecare for health democratization and patient empowerment will be discussed in detail in the first parts of the book. The subsequent sections address several innovation methods with a focus on a novel meta methodology named Purpose Launchpad Health. This is followed by a comprehensive discussion on health entrepreneurship activities and needs. The final section of the book addresses how to train students to become entrepreneurial health innovators, presenting successful curricula and examples of health incubation and accelerator setups. All of the innovation tools presented and used in this book are summarized in the final chapter to help the reader get started planning an entrepreneurial venture.\u003c\/p\u003e\u003cp\u003eWritten by experts from academia and industry, the book covers important basics and best practices, as well as recent developments. Chapters are concise and enriched with key messages, learning objectives and real innovation examples to bridge theory and practice. This book aims to serve as a teaching base for health innovation design and to prepare for health-related entrepreneurial ventures.\u003c\/p\u003e\u003cp\u003eReaders with medical, biomedical, biotechnology, and health economics backgrounds - and anyone who wants to become a future oriented health innovator or who believes in disruptive approaches - will find this book a useful resource and teaching tool for developing validated products\/ services and processes for the future of health.\u003c\/p\u003e\u003cbr\u003e\u003cp\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003ePart I. What Is Wrong with Health? What Should the Future of Health Be?.- \u003c\/b\u003eINNOVATION DESIGN for the FUTURE of HEALTH.- Health Innovations from an Innovators’ Perspective.- From SICKCARE to HEALTHCARE to HEALTH.- Future Look on Health: Opportunities.- Navigating Towards a Future of “One Health”.- \u003cb\u003ePart II. Exponential Medicine + Technologies + Mindset.- \u003c\/b\u003eExponential Technologies for an Exponential Medicine.- Exponential Medicine: Challenges of Human Spaceflight Bringing Innovations for Earth—A Case Study.- Healthy Longevity.- The Science of Health Longevity.- Space Healthtech: Innovation Base for Longevity.- \u003cb\u003ePart III. Future Health Value Propositions.- \u003c\/b\u003eHealthcare the Melting Pot of Technology, Humanity, and Confusion.- Democratize Health Delivery.- Health Innovation Process: Definitions and Short Methodology Introductions.- Prevention, Prediction, Personalization, and Participation as Key Components in Future Health.- Digital Health Business Models: Transformation Is on the Horizon.- Value Propositions for Future Health Developments: Digital, Portable, Connected, Experience-Enhancing, Supportive, Patient-Centric, and Affordable.- (Digital) Patient Journey and Empowerment: Digital Twin.- \u003cb\u003ePart IV. Innovation Methodology Basics.- \u003c\/b\u003eStanford Biodesign as Base: \u003ci\u003eEmpathy and Patient Centricity as the Main Driver\u003c\/i\u003e.- Purpose Launchpad Methodology: Introduction.- Design Thinking for Innovations in Healthcare.- VPC to BMC to Exponential Canvas: Canvas Interconnectivity for Exponential Scaling.- Innovation Methodology I\u003csup\u003e3\u003c\/sup\u003e EME: Awareness for Biomedical Engineers.- \u003cb\u003ePart V. Ethics + Health Innovation.- \u003c\/b\u003eIntegrating Ethical Considerations into Innovation Design.- \u003cb\u003ePart VI. Health Innovation Design.- \u003c\/b\u003eCase Studies Used Throughout the Book: Innovation Categories Explained.- Why Is Healthcare Different with Respect to Innovation and Entrepreneurial Activities?.- Purpose Launchpad Health (PLH) Methodology Introduction.- \u003cb\u003ePart VII. Purpose Launchpad Health.- \u003c\/b\u003ePurpose Launchpad Health: Exploration and Evaluation Phases—Actual Case Studies.- \u003cb\u003ePart VIII. Health Leadership, Skills and other Methodologies.- \u003c\/b\u003eSoft Skills Needed for Problem Understanding and Innovation Generation.- Leadership in Healthcare: A Novel Approach. Healthcare Executives’ Traits, Styles, and Approaches.- Future Skills Framework in Healthcare.- Porter’s Five Forces Analysis: Quo Vadis Immunotherapy Industry.- \u003cb\u003ePart IX. Health Entrepreneurship.- \u003c\/b\u003eGlobal Health Markets and Their Different Needs.- Patient: Health Relation and Digital Health Entrepreneurship.- Health Start-Up: Create Impact and be Investment Ready Intra- and Entre-Preneurs.- Regulatory Issues for Health Innovations.- Innovation Think Tank Frameworks for Resolving “The Innovator’s Dilemma” in Healthcare.- A Primer on Patents and IP for Health Innovations.- Successfully Implementing Ambidexterity in the Medical Industry.- Reverse Innovation: Circumvent Digital Health Transformation Issues.- \u003cb\u003ePart X. Health Innovation Education and Incubation.- \u003c\/b\u003eHealth Innovation Design: “CAMPing” for the Unmet Clinical Need.- Health Technology Innovation Generation (HTIG) Lecture and Project Classes at AGH University.- Health Innovation Design at a University: INKA INNOLAB at Otto-von-Guericke-University.- Clinical Innovation at Acibadem Biodesign Center.- Example of a Needs-Driven Innovation Training Program: The BioMedical Design Novo Nordisk Foundation Fellowship Program.- Addressing the Healthcare Needs with Innovation Think Tank Global Infrastructure and its Methodology.- The Power of a Collaborative Ecosystem: Introducing the Edison™ Accelerator.- HealthTec Networks and Clusters (Global): Innovation Clusters in Medtech in Europe.- Leadership-Compass: “Networking and Synapting Empowered by Health Captains”.- \u003cb\u003ePart XI. Purpose Launchpad Health: Toolset Templates and Principles.- \u003c\/b\u003ePLH Templates and Principles.\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e","brand":"Springer International Publishing AG","offers":[{"title":"Default Title","offer_id":48743068172631,"sku":"9783031081903","price":94.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783031081903.jpg?v=1720063971"},{"product_id":"nanotechnological-approaches-to-the-advancement-of-innovations-in-aquaculture-9783031155185","title":"Nanotechnological Approaches to the Advancement","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe main practical breakthrough of this century is nanobiotechnology, an amalgamation of biology and nanotechnology based on the standards and methods of metabolism. The field mainly involves the analysis, synthesis and the links between molecular biology, nutritional science and nanotechnology. In addition, the field involves the links between other life sciences branches, since the improvement of nanotechnology strategies might be directed by considering the structure and the capability of nanoparticles present in the living cells. \u003cbr\u003eThis book is a comprehensive evaluation of the latest nanobiotechnological developments, with an emphasis on applications, especially in aquaculture. It outlines, in-depth, modern techniques, and includes a variety of important sources that make this the perfect resource for researchers in this captivating world of nanobiotechnology.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003ci\u003e​​Preface\u003c\/i\u003e\u003cbr\u003e\u003cb\u003eChapter 1: Simple Basics of Aquaculture Nanosciences Research: A Thorough Introduction\u003c\/b\u003eDr. Iddaya Karunasagar Senior Fish Safety and Quality Specialist, Fisheries and Aquaculture Department, Food \u0026amp; Agriculture Organisation of UN\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 2: Current Nanotechnology Developments in the Aquaculture Industry\u003c\/b\u003eAhmed A. Tayel, Faculty of Aquatic and Fisheries Sciences Kafrelsheikh University Kafr El Sheikh Egypt\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 3: Aquatic Nanodrug Delivery\u003c\/b\u003eWindell, D, University of Exeter, United Kingdom\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 4: Nanosensors Used in Aquaculture\u003c\/b\u003eJixiang Fang, Xi’an Jiaotong University, China\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 5: Alarming Viral Pathogens in Shrimp Industry and Nanotechnology\u003c\/b\u003eJeyachandran Sivakamavalli, Fisheries Science Institute, Chonnam National University, Yeosu 59626, South Korea\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 6: Bioenrichment of Planktons in Aquaculture through Nanotechnological Approaches\u003c\/b\u003eSivakamavalli, Fisheries Science Institute, Chonnam National University, Yeosu 59626, South KoreaKiyun Parka, Ihn-Sil Kwaka, Faculty of Marine Technology, Chonnam National University, Chonnam 550-749, Republic of Korea\u003cbr\u003e\u003cb\u003eChapter 7: Water Purification and Bioremediation Nanotechnologies\u003c\/b\u003eN. H. Rao, National Academy of Agricultural Research Management, Hyderabad, India\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 8: The Challenge of Nanotechnology-Derived Food\u003c\/b\u003eHarjinder Singh, Riddet Institute, Massey University, New Zealand\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 9: Nanoengineered Particles in Seafood: Their Concentration Level and their Kinetics\u003c\/b\u003eYing-Chou Lee, National Taiwan University, Taiwan\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 10: Harvested Fish Management and Commercialization Packaging\u003c\/b\u003eJH Han, The University of Manitoba, Canada\u003cbr\u003e\u003cbr\u003e\u003cb\u003eChapter 11: Nanotechnologies in Aquaculture Health Issues\u003c\/b\u003eMatheus D.Baldissera, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil\u003cbr\u003e\u003cbr\u003e\u003ci\u003eBibliography\u003c\/i\u003e\u003ci\u003eIndex\u003c\/i\u003e","brand":"Springer International Publishing AG","offers":[{"title":"Default Title","offer_id":48743071514967,"sku":"9783031155185","price":132.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783031155185.jpg?v=1723812629"},{"product_id":"nuclear-medicine-technology-review-questions-for-the-board-examinations-9783031267192","title":"Nuclear Medicine Technology: Review Questions for","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis textbook now published in its 6th edition prepares students and technologists for registry examinations in nuclear medicine technology by providing practice questions and answers with detailed explanations, as well as a mock registry exam. The questions are designed to test the basic knowledge required of nuclear medicine technologists, as well as the practical application of that knowledge.  The topics covered closely follow the content specifications and the components of preparedness as published by the certification boards. This new edition now includes new tracers for diagnostic imaging and therapeutic applications as well as other newly approved procedures. Coverage of positron emission tomography and hybrid multimodality imaging in the field of nuclear medicine and molecular imaging has also been expanded. \u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1 Introduction2 Radioactivity, Radiopharmacy, and Quality Assurance3 Radiation Safety4 Instrumentation and Quality Assurance5 Image Presentation and Computers6 Skeletal System Scintigraphy7 Central Nervous System Scintigraphy8 Cardiovascular System Scintigraphy9 Respiratory System Scintigraphy 10 Gastrointestinal Tract Scintigraphy11 Genitourinary System Scintigraphy12 Oncologic Scintigraphy13 Infection Scintigraphy14 Thyroid, Parathyroid, and Salivary Gland Scintigraphy 15 Non-imaging Procedures and Radionuclide Therapy16 Patient Care17 Positron Emission Tomography18 Multimodality Imaging\u003cbr\u003e","brand":"Springer International Publishing AG","offers":[{"title":"Default Title","offer_id":48743077740887,"sku":"9783031267192","price":71.24,"currency_code":"GBP","in_stock":false}]},{"product_id":"introduction-to-insect-biotechnology-9783031267758","title":"Introduction to Insect Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis textbook introduces to the fundamentals and applications of insect biotechnology in a concise manner. Global economically important insects such as silkworm, lac or honey bee are in the focus of this text. The book attempts to address all of the latest developments in this growing field such as application of metagenomics and proteomics in mining for genes and enzymes that could be beneficial in diverse industrial and biomedical applications. Further, insects have been established as suitable tool for the production of transgenic products which is discussed in one dedicated chapter. \u003c\/p\u003e  The book targets students and researchers in molecular biology, biotechnology or entomology who want to get familiar with the emerging field of insect biotechnology.\u003cp\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Springer International Publishing AG","offers":[{"title":"Default Title","offer_id":48743077937495,"sku":"9783031267758","price":52.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783031267758.jpg?v=1720064014"},{"product_id":"industrial-microbiology-9783527340354","title":"Industrial Microbiology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eFocusing on current and future uses of microbes as production organisms, this practice-oriented textbook complements traditional texts on microbiology and biotechnology.\u003cbr\u003e The editors have brought together leading researchers and professionals from the entire field of industrial microbiology and together they adopt a modern approach to a well-known subject. Following a brief introduction to the technology of microbial processes, the twelve most important application areas for microbial technology are described, from crude bulk chemicals to such highly refined biomolecules as enzymes and antibodies, to the use of microbes in the leaching of minerals and for the treatment of municipal and industrial waste. In line with their application-oriented topic, the authors focus on the \"translation\" of basic research into industrial processes and cite numerous successful examples. The result is a first-hand account of the state of the industry and the future potential for microbes in industrial processes. \u003cbr\u003e Interested students of biotechnology, bioengineering, microbiology and related disciplines will find this a highly useful and much consulted companion, while instructors can use the case studies and examples to add value to their teaching.\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Historical Overview and Future Perspective 1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBernhard Eikmanns, Marcella Eikmanns, and Christopher J. Paddon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Use of Fermentation Procedures Before the Discovery of Microorganisms (Neolithic Era = New Stone Age Until 1850) 1\u003c\/p\u003e \u003cp\u003e1.2 Investigation of Microorganisms and Beginning of Industrial Microbiology (1850 Until 1940) 7\u003c\/p\u003e \u003cp\u003e1.3 Development of New Products and Procedures: Antibiotics and Other Biomolecules (From 1940) 11\u003c\/p\u003e \u003cp\u003e1.4 Genetic Engineering is Introduced into Industrial Microbiology (From Roughly 1980) 15\u003c\/p\u003e \u003cp\u003e1.5 Future Perspectives: Synthetic Microbiology 18\u003c\/p\u003e \u003cp\u003eReferences 20\u003c\/p\u003e \u003cp\u003eFurther Reading 21\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Bioprocess Engineering \u003c\/b\u003e\u003cb\u003e23\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael R. Ladisch, Eduardo Ximenes, Nathan Mosier, Abigail S. Engelberth, Kevin Solomon, and Robert Binkley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 23\u003c\/p\u003e \u003cp\u003e2.1.1 Role of Bioreactors 25\u003c\/p\u003e \u003cp\u003e2.1.2 Basic Bioreactor Configurations 26\u003c\/p\u003e \u003cp\u003e2.1.3 Types of Growth Media 27\u003c\/p\u003e \u003cp\u003e2.2 Nonstructured Models 28\u003c\/p\u003e \u003cp\u003e2.2.1 Nonstructured Growth Models 28\u003c\/p\u003e \u003cp\u003e2.2.1.1 Unstructured Models 29\u003c\/p\u003e \u003cp\u003e2.2.1.2 Biotechnical Processes 30\u003c\/p\u003e \u003cp\u003e2.2.2 Modeling Fermentations 32\u003c\/p\u003e \u003cp\u003e2.2.3 Metabolic Pathways 39\u003c\/p\u003e \u003cp\u003e2.2.4 Manipulation of Metabolic Pathways 40\u003c\/p\u003e \u003cp\u003e2.2.5 Future of Pathway Design 42\u003c\/p\u003e \u003cp\u003e2.3 Oxygen Transport 43\u003c\/p\u003e \u003cp\u003e2.3.1 Aerobic versus Anaerobic Conditions 43\u003c\/p\u003e \u003cp\u003e2.3.2 k\u003csub\u003eL\u003c\/sub\u003ea – Volumetric Mass Transfer Coefficient 44\u003c\/p\u003e \u003cp\u003e2.4 Heat Generating Aerobic Processes 46\u003c\/p\u003e \u003cp\u003e2.5 Product Recovery 49\u003c\/p\u003e \u003cp\u003e2.5.1 Basics 49\u003c\/p\u003e \u003cp\u003e2.5.2 \u003ci\u003eIn Situ \u003c\/i\u003eProduct Recovery (ISPR) 49\u003c\/p\u003e \u003cp\u003e2.6 Modeling and Simulation of Reactor Behavior 51\u003c\/p\u003e \u003cp\u003e2.6.1 Basic Approaches and Software 51\u003c\/p\u003e \u003cp\u003e2.6.2 Numerical Simulation of Bioreactor Function 51\u003c\/p\u003e \u003cp\u003e2.6.3 Contamination of Bioreactors 52\u003c\/p\u003e \u003cp\u003e2.7 Scale-up 53\u003c\/p\u003e \u003cp\u003eReferences 54\u003c\/p\u003e \u003cp\u003eFurther Reading 57\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Food \u003c\/b\u003e\u003cb\u003e59\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGülhan Ünlü and Barbara Nielsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Fermented Foods 59\u003c\/p\u003e \u003cp\u003e3.1.1 Food Preservation 59\u003c\/p\u003e \u003cp\u003e3.1.2 Flavor and Texture 60\u003c\/p\u003e \u003cp\u003e3.1.3 Health Benefits 60\u003c\/p\u003e \u003cp\u003e3.1.4 Economic Impact 62\u003c\/p\u003e \u003cp\u003e3.2 Microorganisms and Metabolism 62\u003c\/p\u003e \u003cp\u003e3.2.1 Fermentation Processes 64\u003c\/p\u003e \u003cp\u003e3.2.2 Starter Cultures 65\u003c\/p\u003e \u003cp\u003e3.3 Yeast Fermentations – Industrial Application of \u003ci\u003eSaccharomyces \u003c\/i\u003eSpecies 65\u003c\/p\u003e \u003cp\u003e3.3.1 Grain Fermentation for Ethanol Production – Beer 66\u003c\/p\u003e \u003cp\u003e3.3.2 Grain Fermentation for CO\u003csub\u003e2\u003c\/sub\u003e Production – Bread 69\u003c\/p\u003e \u003cp\u003e3.3.2.1 Yeast Preparation 69\u003c\/p\u003e \u003cp\u003e3.3.3 Fruit Fermentation –Wines and Ciders 71\u003c\/p\u003e \u003cp\u003e3.4 Vinegar – Incomplete Ethanol Oxidation by Acetic Acid Bacteria Such as \u003ci\u003eGluconobacter oxydans \u003c\/i\u003e75\u003c\/p\u003e \u003cp\u003e3.4.1 Substrates: Wine, Cider, and Malt 75\u003c\/p\u003e \u003cp\u003e3.4.2 Distilled (White) Vinegar 77\u003c\/p\u003e \u003cp\u003e3.4.3 Balsamic and Other Specialty Vinegars 77\u003c\/p\u003e \u003cp\u003e3.5 Bacterial and Mixed Fermentations – Industrial Application of Lactic Acid Bacteria, with or without Yeast or Molds 78\u003c\/p\u003e \u003cp\u003e3.5.1 Milk – Cultured Milks – Buttermilk, Yogurt, Kefir, and Cheese 78\u003c\/p\u003e \u003cp\u003e3.5.1.1 Bacteriophage Contamination – Death of a Culture 81\u003c\/p\u003e \u003cp\u003e3.5.2 Meats – Sausages, Fish Sauces, and Pastes 82\u003c\/p\u003e \u003cp\u003e3.5.3 Vegetables – Sauerkrauts and Pickles, Olives 83\u003c\/p\u003e \u003cp\u003e3.5.4 Grains and Legumes – Soy Sauce, Miso, Natto, and Tempeh 86\u003c\/p\u003e \u003cp\u003e3.5.5 Cocoa and Coffee 87\u003c\/p\u003e \u003cp\u003e3.6 Fungi as Food 88\u003c\/p\u003e \u003cp\u003e3.6.1 Mushrooms 88\u003c\/p\u003e \u003cp\u003e3.6.2 Single-Cell Protein – \u003ci\u003eFusarium venenatum \u003c\/i\u003e90\u003c\/p\u003e \u003cp\u003e3.7 Conclusions and Outlook 91\u003c\/p\u003e \u003cp\u003eReferences 92\u003c\/p\u003e \u003cp\u003eFurther Reading 92\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Technical Alcohols and Ketones \u003c\/b\u003e\u003cb\u003e95\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePeter Dürre\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 95\u003c\/p\u003e \u003cp\u003e4.2 Ethanol Synthesis by \u003ci\u003eSaccharomyces cerevisiae \u003c\/i\u003eand \u003ci\u003eClostridium autoethanogenum \u003c\/i\u003e97\u003c\/p\u003e \u003cp\u003e4.2.1 Application 97\u003c\/p\u003e \u003cp\u003e4.2.2 Metabolic Pathways and Regulation 97\u003c\/p\u003e \u003cp\u003e4.2.3 Production Strains 98\u003c\/p\u003e \u003cp\u003e4.2.4 Production Processes 98\u003c\/p\u003e \u003cp\u003e4.2.5 Ethanol – Fuel of the Future? 100\u003c\/p\u003e \u003cp\u003e4.2.6 Alternative Substrates for Ethanol Fermentation by Cellulolytic Bacteria and \u003ci\u003eClostridium autoethanogenum \u003c\/i\u003e100\u003c\/p\u003e \u003cp\u003e4.3 1,3-Propanediol Synthesis by \u003ci\u003eEscherichia coli \u003c\/i\u003e101\u003c\/p\u003e \u003cp\u003e4.3.1 Application 101\u003c\/p\u003e \u003cp\u003e4.3.2 Metabolic Pathways and Regulation 102\u003c\/p\u003e \u003cp\u003e4.3.3 Production Strains 102\u003c\/p\u003e \u003cp\u003e4.3.4 Production Processes 104\u003c\/p\u003e \u003cp\u003e4.4 Butanol and Isobutanol Synthesis by Clostridia and Yeast 105\u003c\/p\u003e \u003cp\u003e4.4.1 History of Acetone–Butanol–Ethanol (ABE) Fermentation by \u003ci\u003eClostridium acetobutylicum \u003c\/i\u003eand \u003ci\u003eC. beijerinckii \u003c\/i\u003e105\u003c\/p\u003e \u003cp\u003e4.4.2 Application 106\u003c\/p\u003e \u003cp\u003e4.4.3 Metabolic Pathways and Regulation 107\u003c\/p\u003e \u003cp\u003e4.4.4 Production Strains 110\u003c\/p\u003e \u003cp\u003e4.4.5 Production Processes 110\u003c\/p\u003e \u003cp\u003e4.4.6 Product Toxicity 113\u003c\/p\u003e \u003cp\u003e4.5 Acetone Synthesis by Solventogenic Clostridia 113\u003c\/p\u003e \u003cp\u003e4.5.1 Application 113\u003c\/p\u003e \u003cp\u003e4.5.2 Metabolic Pathways and Regulation 113\u003c\/p\u003e \u003cp\u003e4.5.3 Production Strains 114\u003c\/p\u003e \u003cp\u003e4.5.4 Production Processes 114\u003c\/p\u003e \u003cp\u003e4.6 Outlook 115\u003c\/p\u003e \u003cp\u003eFurther Reading 115\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Organic Acids \u003c\/b\u003e\u003cb\u003e117\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael Sauer and Diethard Mattanovich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 117\u003c\/p\u003e \u003cp\u003e5.2 Citric Acid 119\u003c\/p\u003e \u003cp\u003e5.2.1 Economic Impact and Applications 120\u003c\/p\u003e \u003cp\u003e5.2.2 Biochemistry of Citric Acid Accumulation 120\u003c\/p\u003e \u003cp\u003e5.2.3 Industrial Production by the Filamentous Fungus \u003ci\u003eAspergillus niger \u003c\/i\u003e122\u003c\/p\u003e \u003cp\u003e5.2.4 \u003ci\u003eYarrowia lipolytica\u003c\/i\u003e: A Yeast as an Alternative Production Platform 123\u003c\/p\u003e \u003cp\u003e5.3 Lactic Acid 124\u003c\/p\u003e \u003cp\u003e5.3.1 Economic Impact and Applications 124\u003c\/p\u003e \u003cp\u003e5.3.2 Anaerobic Bacterial Metabolism Generating Lactic Acid 125\u003c\/p\u003e \u003cp\u003e5.3.3 Lactic Acid Production by Bacteria 125\u003c\/p\u003e \u003cp\u003e5.3.4 Lactic Acid Production by Yeasts 126\u003c\/p\u003e \u003cp\u003e5.4 Gluconic Acid 127\u003c\/p\u003e \u003cp\u003e5.4.1 Economic Impact and Applications 127\u003c\/p\u003e \u003cp\u003e5.4.2 Extracellular Biotransformation of Glucose to Gluconic Acid by \u003ci\u003eAspergillus niger \u003c\/i\u003e128\u003c\/p\u003e \u003cp\u003e5.4.3 Production of Gluconic Acid by Bacteria 129\u003c\/p\u003e \u003cp\u003e5.5 Succinic Acid 129\u003c\/p\u003e \u003cp\u003e5.5.1 Economic Impact and Applications 130\u003c\/p\u003e \u003cp\u003e5.5.2 Pilot Plants for Anaerobic or Aerobic Microbes 130\u003c\/p\u003e \u003cp\u003e5.6 Itaconic Acid 132\u003c\/p\u003e \u003cp\u003e5.6.1 Economic Impact and Applications 132\u003c\/p\u003e \u003cp\u003e5.6.2 Decarboxylation as a Driver in Itaconic Acid Accumulation 132\u003c\/p\u003e \u003cp\u003e5.6.3 Production Process by \u003ci\u003eAspergillus terreus \u003c\/i\u003e132\u003c\/p\u003e \u003cp\u003e5.6.4 Metabolic Engineering for Itaconic Acid Production 132\u003c\/p\u003e \u003cp\u003e5.7 Downstream Options for Organic Acids 134\u003c\/p\u003e \u003cp\u003e5.8 Perspectives 135\u003c\/p\u003e \u003cp\u003e5.8.1 Targeting Acrylic Acid – Microbes Can Replace Chemical Process Engineering 136\u003c\/p\u003e \u003cp\u003e5.8.2 Lignocellulose-Based Biorefineries 136\u003c\/p\u003e \u003cp\u003eFurther Reading 137\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Amino Acids \u003c\/b\u003e\u003cb\u003e139\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLothar Eggeling\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 139\u003c\/p\u003e \u003cp\u003e6.1.1 Importance and Areas of Application 139\u003c\/p\u003e \u003cp\u003e6.1.2 Amino Acids in the Feed Industry 140\u003c\/p\u003e \u003cp\u003e6.1.3 Economic Significance 141\u003c\/p\u003e \u003cp\u003e6.2 Production of Amino Acids 142\u003c\/p\u003e \u003cp\u003e6.2.1 Conventional Development of Production Strains 142\u003c\/p\u003e \u003cp\u003e6.2.2 Advanced Development of Production Strains 144\u003c\/p\u003e \u003cp\u003e6.3 l-Glutamate Synthesis by \u003ci\u003eCorynebacterium glutamicum \u003c\/i\u003e145\u003c\/p\u003e \u003cp\u003e6.3.1 Synthesis Pathway and Regulation 145\u003c\/p\u003e \u003cp\u003e6.3.2 Production Process 148\u003c\/p\u003e \u003cp\u003e6.4 l-Lysine 148\u003c\/p\u003e \u003cp\u003e6.4.1 Synthesis Pathway and Regulation 148\u003c\/p\u003e \u003cp\u003e6.4.2 Production Strains 150\u003c\/p\u003e \u003cp\u003e6.4.3 Production Process 152\u003c\/p\u003e \u003cp\u003e6.5 l-Threonine Synthesis by \u003ci\u003eEscherichia coli \u003c\/i\u003e153\u003c\/p\u003e \u003cp\u003e6.5.1 Synthesis Pathway and Regulation 153\u003c\/p\u003e \u003cp\u003e6.5.2 Production Strains 154\u003c\/p\u003e \u003cp\u003e6.5.3 Production Process 155\u003c\/p\u003e \u003cp\u003e6.6 l-Phenylalanine 155\u003c\/p\u003e \u003cp\u003e6.6.1 Synthesis Pathway and Regulation 155\u003c\/p\u003e \u003cp\u003e6.6.2 Production Strains 156\u003c\/p\u003e \u003cp\u003e6.6.3 Production Process 157\u003c\/p\u003e \u003cp\u003e6.7 Outlook 158\u003c\/p\u003e \u003cp\u003eFurther Reading 159\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Vitamins, Nucleotides, and Carotenoids \u003c\/b\u003e\u003cb\u003e161\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKlaus-Peter Stahmann and Hans-Peter Hohmann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Application and Economic Impact 161\u003c\/p\u003e \u003cp\u003e7.2 l-Ascorbic Acid (Vitamin C) 163\u003c\/p\u003e \u003cp\u003e7.2.1 Biochemical Significance, Application, and Biosynthesis 163\u003c\/p\u003e \u003cp\u003e7.2.2 Regioselective Oxidation with Bacteria in the Production Process 164\u003c\/p\u003e \u003cp\u003e7.3 Riboflavin (Vitamin B\u003csub\u003e2\u003c\/sub\u003e) 166\u003c\/p\u003e \u003cp\u003e7.3.1 Significance as a Precursor for Coenzymes and as a Pigment 166\u003c\/p\u003e \u003cp\u003e7.3.2 Biosynthesis by Fungi and Bacteria 167\u003c\/p\u003e \u003cp\u003e7.3.3 Production by \u003ci\u003eAshbya gossypii \u003c\/i\u003e168\u003c\/p\u003e \u003cp\u003e7.3.4 Production by \u003ci\u003eBacillus subtilis \u003c\/i\u003e171\u003c\/p\u003e \u003cp\u003e7.3.5 Downstream Processing and Environmental Compatibility 173\u003c\/p\u003e \u003cp\u003e7.4 Cobalamin (Vitamin B\u003csub\u003e12\u003c\/sub\u003e) 174\u003c\/p\u003e \u003cp\u003e7.4.1 Physiological Relevance 174\u003c\/p\u003e \u003cp\u003e7.4.2 Biosynthesis 176\u003c\/p\u003e \u003cp\u003e7.4.3 Production with \u003ci\u003ePseudomonas denitrificans \u003c\/i\u003e176\u003c\/p\u003e \u003cp\u003e7.5 Purine Nucleotides 178\u003c\/p\u003e \u003cp\u003e7.5.1 Impact as Flavor Enhancer 178\u003c\/p\u003e \u003cp\u003e7.5.2 Development of Production Strains 178\u003c\/p\u003e \u003cp\u003e7.5.3 Production of Inosine or Guanosine with Subsequent Phosphorylation 179\u003c\/p\u003e \u003cp\u003e7.6 β-Carotene 180\u003c\/p\u003e \u003cp\u003e7.6.1 Physiological Impact and Application 180\u003c\/p\u003e \u003cp\u003e7.6.2 Production with \u003ci\u003eBlakeslea trispora \u003c\/i\u003e181\u003c\/p\u003e \u003cp\u003e7.7 Perspectives 181\u003c\/p\u003e \u003cp\u003eFurther Reading 183\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Antibiotics and Pharmacologically Active Compounds \u003c\/b\u003e\u003cb\u003e185\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLei Fang, Guojian Zhang, and Blaine A. Pfeifer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Microbial Substances Active Against Infectious Disease Agents or Affecting Human Cells 185\u003c\/p\u003e \u003cp\u003e8.1.1 Distribution and Impacts 185\u003c\/p\u003e \u003cp\u003e8.1.2 Diversity of Antibiotics Produced by Bacteria and Fungi 189\u003c\/p\u003e \u003cp\u003e8.2 β-Lactams 190\u003c\/p\u003e \u003cp\u003e8.2.1 History, Effect, and Application 190\u003c\/p\u003e \u003cp\u003e8.2.2 β-Lactam Biosynthesis 190\u003c\/p\u003e \u003cp\u003e8.2.3 Penicillin Production by \u003ci\u003ePenicillium chrysogenum \u003c\/i\u003e193\u003c\/p\u003e \u003cp\u003e8.2.4 Cephalosporin Production by \u003ci\u003eAcremonium chrysogenum \u003c\/i\u003e193\u003c\/p\u003e \u003cp\u003e8.3 Lipopeptides 193\u003c\/p\u003e \u003cp\u003e8.3.1 History, Effect, and Application 193\u003c\/p\u003e \u003cp\u003e8.3.2 Lipopeptide Biosynthesis 194\u003c\/p\u003e \u003cp\u003e8.3.3 Daptomycin Production by \u003ci\u003eStreptomyces roseosporus \u003c\/i\u003e194\u003c\/p\u003e \u003cp\u003e8.3.4 Cyclosporine Production by \u003ci\u003eTolypocladium inflatum \u003c\/i\u003e194\u003c\/p\u003e \u003cp\u003e8.4 Macrolides 197\u003c\/p\u003e \u003cp\u003e8.4.1 History, Effect, and Application 197\u003c\/p\u003e \u003cp\u003e8.4.2 Macrolide Biosynthesis 197\u003c\/p\u003e \u003cp\u003e8.4.3 Erythromycin Production by \u003ci\u003eSaccharopolyspora erythraea \u003c\/i\u003e197\u003c\/p\u003e \u003cp\u003e8.5 Tetracyclines 200\u003c\/p\u003e \u003cp\u003e8.5.1 History, Effect, and Application 200\u003c\/p\u003e \u003cp\u003e8.5.2 Tetracycline Biosynthesis 200\u003c\/p\u003e \u003cp\u003e8.5.3 Tetracycline Production by \u003ci\u003eStreptomyces rimosus \u003c\/i\u003e201\u003c\/p\u003e \u003cp\u003e8.6 Aminoglycosides 201\u003c\/p\u003e \u003cp\u003e8.6.1 History, Effect, and Application 201\u003c\/p\u003e \u003cp\u003e8.6.2 Aminoglycoside Biosynthesis 201\u003c\/p\u003e \u003cp\u003e8.6.3 Tobramycin Production by \u003ci\u003eStreptomyces tenebrarius \u003c\/i\u003e203\u003c\/p\u003e \u003cp\u003e8.7 Claviceps Alkaloids 203\u003c\/p\u003e \u003cp\u003e8.7.1 History, Effect, and Application 203\u003c\/p\u003e \u003cp\u003e8.7.2 Alkaloid Biosynthesis 203\u003c\/p\u003e \u003cp\u003e8.7.3 Ergotamine Production by \u003ci\u003eClaviceps purpurea \u003c\/i\u003e203\u003c\/p\u003e \u003cp\u003e8.8 Perspectives 203\u003c\/p\u003e \u003cp\u003e8.8.1 Antibiotic Resistance 203\u003c\/p\u003e \u003cp\u003e8.8.2 New Research Model for Compound Identification 206\u003c\/p\u003e \u003cp\u003e8.8.3 Future Opportunities 207\u003c\/p\u003e \u003cp\u003eFurther Reading 211\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Pharmaceutical Proteins \u003c\/b\u003e\u003cb\u003e213\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHeinrich Decker, Susanne Dilsen, and Jan Weber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 History, Main Areas of Application, and Economic Importance 213\u003c\/p\u003e \u003cp\u003e9.2 Industrial Expression Systems, Cultivation and Protein Isolation, and Legal Framework 215\u003c\/p\u003e \u003cp\u003e9.2.1 Development of Production Strains 215\u003c\/p\u003e \u003cp\u003e9.2.2 Isolation of Pharmaceutical Proteins 221\u003c\/p\u003e \u003cp\u003e9.2.3 Regulatory Requirements for the Production of Pharmaceutical Proteins 222\u003c\/p\u003e \u003cp\u003e9.3 Insulins 223\u003c\/p\u003e \u003cp\u003e9.3.1 Application and Structures 223\u003c\/p\u003e \u003cp\u003e9.3.2 Manufacturing Processes by \u003ci\u003eEscherichia coli \u003c\/i\u003eand \u003ci\u003eSaccharomyces cerevisiae \u003c\/i\u003e225\u003c\/p\u003e \u003cp\u003e9.3.2.1 Production of a Fusion Protein in \u003ci\u003eE. coli \u003c\/i\u003e226\u003c\/p\u003e \u003cp\u003e9.3.2.2 Production of a Precursor Protein, the So-Called Mini Proinsulin with the Host Strain \u003ci\u003eS. cerevisiae \u003c\/i\u003e228\u003c\/p\u003e \u003cp\u003e9.4 Somatropin 230\u003c\/p\u003e \u003cp\u003e9.4.1 Application 230\u003c\/p\u003e \u003cp\u003e9.4.2 Manufacturing Process 231\u003c\/p\u003e \u003cp\u003e9.5 Interferons – Application and Manufacturing 232\u003c\/p\u003e \u003cp\u003e9.6 Human Granulocyte Colony-Stimulating Factor 234\u003c\/p\u003e \u003cp\u003e9.6.1 Application 234\u003c\/p\u003e \u003cp\u003e9.6.2 Manufacturing Process 235\u003c\/p\u003e \u003cp\u003e9.7 Vaccines 235\u003c\/p\u003e \u003cp\u003e9.7.1 Application 235\u003c\/p\u003e \u003cp\u003e9.7.2 Manufacturing Procedure Using the Example of Gardasil\u003csup\u003eTM\u003c\/sup\u003e 236\u003c\/p\u003e \u003cp\u003e9.7.3 Manufacturing Process Based on the Example of a Hepatitis B Vaccine 237\u003c\/p\u003e \u003cp\u003e9.8 Antibody Fragments 238\u003c\/p\u003e \u003cp\u003e9.9 Enzymes 239\u003c\/p\u003e \u003cp\u003e9.10 Peptides 240\u003c\/p\u003e \u003cp\u003e9.11 View – Future Economic Importance 240\u003c\/p\u003e \u003cp\u003eFurther Reading 242\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Enzymes \u003c\/b\u003e\u003cb\u003e243\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDavid B.Wilson, Maxim Kostylev, Karl-Heinz Maurer, Marina Schramm, Wolfgang Kronemeyer, and Klaus-Peter Stahmann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Fields of Application and Economic Impacts 243\u003c\/p\u003e \u003cp\u003e10.1.1 Enzymes are Biocatalysts 243\u003c\/p\u003e \u003cp\u003e10.1.2 Advantages and Limitations of Using Enzymatic Versus Chemical Methods 244\u003c\/p\u003e \u003cp\u003e10.1.3 Brief History of Enzyme Used for the Industrial Production of Valuable Products 245\u003c\/p\u003e \u003cp\u003e10.1.4 Diverse Ways That Enzymes are Used in Industry 246\u003c\/p\u003e \u003cp\u003e10.2 Enzyme Discovery and Improvement 250\u003c\/p\u003e \u003cp\u003e10.2.1 Screening for New Enzymes and Optimization of Enzymes by Protein Engineering 250\u003c\/p\u003e \u003cp\u003e10.2.2 Classical Development of Production Strains 251\u003c\/p\u003e \u003cp\u003e10.2.3 Genetic Engineering of Producer Strains 253\u003c\/p\u003e \u003cp\u003e10.3 Production Process for Bacterial or Fungal Enzymes 255\u003c\/p\u003e \u003cp\u003e10.4 Polysaccharide-Hydrolyzing Enzymes 255\u003c\/p\u003e \u003cp\u003e10.4.1 Starch-Cleaving Enzymes Produced by \u003ci\u003eBacillus \u003c\/i\u003eand \u003ci\u003eAspergillus \u003c\/i\u003eSpecies 257\u003c\/p\u003e \u003cp\u003e10.4.2 Cellulose-Cleaving Enzymes: A Domain of \u003ci\u003eTrichoderma reesei \u003c\/i\u003e259\u003c\/p\u003e \u003cp\u003e10.4.3 Production Strains 261\u003c\/p\u003e \u003cp\u003e10.5 Enzymes Used as Cleaning Agents 263\u003c\/p\u003e \u003cp\u003e10.5.1 Subtilisin-Like Protease 264\u003c\/p\u003e \u003cp\u003e10.5.2 \u003ci\u003eBacillus \u003c\/i\u003esp. Production Strains and Production Process 265\u003c\/p\u003e \u003cp\u003e10.6 Feed Supplements – Phytases 266\u003c\/p\u003e \u003cp\u003e10.6.1 Fields of Applications of Phytase 267\u003c\/p\u003e \u003cp\u003e10.6.2 Phytase in the Animals Intestine 267\u003c\/p\u003e \u003cp\u003e10.6.3 Production of a Bacterial Phytase in \u003ci\u003eAspergillus niger \u003c\/i\u003e269\u003c\/p\u003e \u003cp\u003e10.7 Enzymes for Chemical and Pharmaceutical Industry 271\u003c\/p\u003e \u003cp\u003e10.7.1 Examples for Enzymatic Chemical Production 271\u003c\/p\u003e \u003cp\u003e10.7.2 Production of (\u003ci\u003eS\u003c\/i\u003e)-Profens by Fungal Lipase 271\u003c\/p\u003e \u003cp\u003e10.8 Enzymes as Highly Selective Tools for Research and Diagnostics 272\u003c\/p\u003e \u003cp\u003e10.8.1 Microbial Enzymes for Analysis and Engineering of Nucleic Acids 272\u003c\/p\u003e \u003cp\u003e10.8.2 Specific Enzymes for Quantitative Metabolite Assays 275\u003c\/p\u003e \u003cp\u003e10.9 Perspectives 276\u003c\/p\u003e \u003cp\u003e10.9.1 l-DOPA by Tyrosine Phenol Lyase 276\u003c\/p\u003e \u003cp\u003e10.9.2 Activation of Alkanes 276\u003c\/p\u003e \u003cp\u003e10.9.3 Enzyme Cascades 276\u003c\/p\u003e \u003cp\u003eReferences 277\u003c\/p\u003e \u003cp\u003eFurther Reading 277\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Microbial Polysaccharides \u003c\/b\u003e\u003cb\u003e279\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eVolker Sieber, Jochen Schmid, and Gerd Hublik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 279\u003c\/p\u003e \u003cp\u003e11.2 Heteropolysaccharides 282\u003c\/p\u003e \u003cp\u003e11.2.1 Xanthan: A Product of the Bacterium \u003ci\u003eXanthomonas campestris \u003c\/i\u003e282\u003c\/p\u003e \u003cp\u003e11.2.1.1 Introduction 282\u003c\/p\u003e \u003cp\u003e11.2.1.2 Regulatory Status 282\u003c\/p\u003e \u003cp\u003e11.2.1.3 Structure 282\u003c\/p\u003e \u003cp\u003e11.2.1.4 Biosynthesis 284\u003c\/p\u003e \u003cp\u003e11.2.1.5 Industrial Production of Xanthan 286\u003c\/p\u003e \u003cp\u003e11.2.1.6 Physicochemical Properties 287\u003c\/p\u003e \u003cp\u003e11.2.1.7 Applications 289\u003c\/p\u003e \u003cp\u003e11.2.2 Sphingans: Polysaccharides from \u003ci\u003eSphingomonas \u003c\/i\u003esp. 291\u003c\/p\u003e \u003cp\u003e11.2.3 Hyaluronic Acid: A High-Value Polysaccharide for Cosmetic Applications 293\u003c\/p\u003e \u003cp\u003e11.2.4 Alginate: Alternatives to Plant-Based Products by \u003ci\u003ePseudomonas \u003c\/i\u003eand \u003ci\u003eAzotobacter \u003c\/i\u003esp. 294\u003c\/p\u003e \u003cp\u003e11.2.5 Succinoglycan: Acidic Polysaccharide from \u003ci\u003eRhizobium \u003c\/i\u003esp. 294\u003c\/p\u003e \u003cp\u003e11.3 Homopolysaccharides 295\u003c\/p\u003e \u003cp\u003e11.3.1 α-Glucans 296\u003c\/p\u003e \u003cp\u003e11.3.1.1 Pullulan 296\u003c\/p\u003e \u003cp\u003e11.3.1.2 Dextran 296\u003c\/p\u003e \u003cp\u003e11.3.2 β-Glucans 297\u003c\/p\u003e \u003cp\u003e11.3.2.1 Linear β-glucans like cellulose and curdlan 297\u003c\/p\u003e \u003cp\u003e11.3.2.2 Branched β-Glucans Like Scleroglucan and Schizophyllan 297\u003c\/p\u003e \u003cp\u003e11.3.3 Fructosylpolymers like Levan 298\u003c\/p\u003e \u003cp\u003e11.4 Perspectives 298\u003c\/p\u003e \u003cp\u003eFurther Reading 299\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Steroids \u003c\/b\u003e\u003cb\u003e301\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShuvendu Das and Sridhar Gopishetty\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Fields of Applications and Economic Importance 301\u003c\/p\u003e \u003cp\u003e12.2 Advantages of Biotransformations During Production of Steroids 303\u003c\/p\u003e \u003cp\u003e12.3 Development of Production Strains and Production Processes 305\u003c\/p\u003e \u003cp\u003e12.4 Applied Types of Biotransformation 307\u003c\/p\u003e \u003cp\u003e12.5 Synthesis of Steroids in Organic – Aqueous Biphasic System 310\u003c\/p\u003e \u003cp\u003e12.6 Side-chain Degradation of Phytosterols by \u003ci\u003eMycobacterium \u003c\/i\u003eto Gain Steroid Intermediates 311\u003c\/p\u003e \u003cp\u003e12.7 Biotransformation of Cholesterol to Gain Key Steroid Intermediates 313\u003c\/p\u003e \u003cp\u003e12.8 11-Hydroxylation by Fungi During Synthesis of Corticosteroids 313\u003c\/p\u003e \u003cp\u003e12.9 Δ1-Dehydrogenation by \u003ci\u003eArthrobacter \u003c\/i\u003efor the Production of Prednisolone 316\u003c\/p\u003e \u003cp\u003e12.10 17-Keto Reduction by \u003ci\u003eSaccharomyces \u003c\/i\u003ein Testosterone Production 317\u003c\/p\u003e \u003cp\u003e12.11 Double-Bond Isomerization of Steroids 318\u003c\/p\u003e \u003cp\u003e12.12 Perspectives 319\u003c\/p\u003e \u003cp\u003eReferences 320\u003c\/p\u003e \u003cp\u003eFurther Reading 321\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Bioleaching \u003c\/b\u003e\u003cb\u003e323\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSören Bellenberg, Mario Vera Véliz, and Wolfgang Sand\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Acidophilic Microorganisms Dissolve Metals from Sulfide Ores 323\u003c\/p\u003e \u003cp\u003e13.1.1 Brief Overview on the Diversity of Acidophilic Mineral-Oxidizing Microorganisms 325\u003c\/p\u003e \u003cp\u003e13.1.2 Natural and Man-Made Habitats of Mineral-oxidizing Microorganisms 325\u003c\/p\u003e \u003cp\u003e13.1.3 Biological Catalysis of Metal Sulfide Oxidation 328\u003c\/p\u003e \u003cp\u003e13.1.4 Importance of Biofilm Formation and Extracellular Polymeric Substances for Bioleaching by \u003ci\u003eAcidithiobacillus ferrooxidans \u003c\/i\u003eand \u003ci\u003eLeptospirillum ferrooxidans \u003c\/i\u003e330\u003c\/p\u003e \u003cp\u003e13.2 Bioleaching of Copper, Nickel, Zinc, and Cobalt 334\u003c\/p\u003e \u003cp\u003e13.2.1 Economic Impact 334\u003c\/p\u003e \u003cp\u003e13.2.2 Heap, Dump, or Stirred-tank Bioleaching of Copper, Nickel, Zinc, and Cobalt 337\u003c\/p\u003e \u003cp\u003e13.3 Gold 342\u003c\/p\u003e \u003cp\u003e13.3.1 Economic Impact 343\u003c\/p\u003e \u003cp\u003e13.3.2 Unlocking Gold by Biooxidation of the Mineral Matrix 343\u003c\/p\u003e \u003cp\u003e13.4 Uranium 346\u003c\/p\u003e \u003cp\u003e13.4.1 Economic Impact 346\u003c\/p\u003e \u003cp\u003e13.4.2 \u003ci\u003eIn Situ \u003c\/i\u003eBiomining of Uranium 346\u003c\/p\u003e \u003cp\u003e13.5 Perspectives 347\u003c\/p\u003e \u003cp\u003e13.5.1 Urban Mining – Processing of Electronic Waste and Industrial Residues 347\u003c\/p\u003e \u003cp\u003e13.5.2 Microbial Iron Reduction for Dissolution of Mineral Oxides 348\u003c\/p\u003e \u003cp\u003e13.5.3 Biomining Goes Underground – \u003ci\u003eIn Situ \u003c\/i\u003eLeaching as a Green Mining Technology? 348\u003c\/p\u003e \u003cp\u003eReferences 351\u003c\/p\u003e \u003cp\u003eFurther Reading 351\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Wastewater Treatment Processes \u003c\/b\u003e\u003cb\u003e353\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eClaudia Gallert and Josef Winter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 354\u003c\/p\u003e \u003cp\u003e14.1.1 Historical Development of Sewage Treatment 354\u003c\/p\u003e \u003cp\u003e14.1.2 Resources from Wastewater Treatment 357\u003c\/p\u003e \u003cp\u003e14.1.3 Wastewater and Storm Water Drainage 358\u003c\/p\u003e \u003cp\u003e14.1.4 Wastewater Characterization and Processes for Effective Wastewater Treatment 358\u003c\/p\u003e \u003cp\u003e14.1.5 Suspended or Immobilized Bacteria as Biocatalysts for Effective Sewage Treatment 360\u003c\/p\u003e \u003cp\u003e14.2 Biological Basics of Carbon, Nitrogen, and Phosphorus Removal from Sewage 362\u003c\/p\u003e \u003cp\u003e14.2.1 Aerobic and Anaerobic Degradation of Carbon Compounds 362\u003c\/p\u003e \u003cp\u003e14.2.1.1 Mass and Energy Balance 366\u003c\/p\u003e \u003cp\u003e14.2.2 Fundamentals of Nitrification 368\u003c\/p\u003e \u003cp\u003e14.2.3 Elimination of Nitrate by Denitrification 371\u003c\/p\u003e \u003cp\u003e14.2.4 New Nitrogen Elimination Processes 371\u003c\/p\u003e \u003cp\u003e14.2.5 Microbial Phosphate Elimination 372\u003c\/p\u003e \u003cp\u003e14.3 Wastewater Treatment Processes 374\u003c\/p\u003e \u003cp\u003e14.3.1 Typical Process Sequence in Municipal Sewage Treatment Plants 374\u003c\/p\u003e \u003cp\u003e14.3.2 Activated Sludge Process 376\u003c\/p\u003e \u003cp\u003e14.3.3 Trickling Filters 378\u003c\/p\u003e \u003cp\u003e14.3.4 Technical Options for Denitrification 379\u003c\/p\u003e \u003cp\u003e14.3.5 Biological Phosphate Elimination 381\u003c\/p\u003e \u003cp\u003e14.3.6 Sewage Sludge Treatment 382\u003c\/p\u003e \u003cp\u003e14.3.6.1 Aerobic and Anaerobic Sewage Sludge Treatment 382\u003c\/p\u003e \u003cp\u003e14.3.6.2 Sanitation and Quality Assurance of Sewage Sludge 384\u003c\/p\u003e \u003cp\u003e14.4 Advanced Wastewater Treatment 384\u003c\/p\u003e \u003cp\u003e14.4.1 Elimination of Micropollutants 385\u003c\/p\u003e \u003cp\u003e14.4.2 Wastewater Disinfection 385\u003c\/p\u003e \u003cp\u003e14.5 Future Perspectives 386\u003c\/p\u003e \u003cp\u003eReferences 386\u003c\/p\u003e \u003cp\u003eFurther Reading 388\u003c\/p\u003e \u003cp\u003eIndex 389\u003c\/p\u003e","brand":"Wiley-VCH Verlag GmbH","offers":[{"title":"Default Title","offer_id":48743119454551,"sku":"9783527340354","price":52.7,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783527340354.jpg?v=1720064195"},{"product_id":"point-of-care-biosensors-for-infectious-diseases-9783527350452","title":"Point-of-Care Biosensors for Infectious Diseases","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePoint-of-Care Biosensors for Infectious Diseases\u003c\/b\u003e \u003cp\u003e\u003cb\u003eComprehensive resource covering key developments in biosensor-based diagnostics for infectious diseases\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eWith its overview of currently available technologies, \u003ci\u003ePoint-of-Care Biosensors for Infectious Diseases\u003c\/i\u003e serves as a starting point for the successful development and application of pathogen biosensors in a point-of-care setting. Here, expert authors review current challenges in pathogen detection and the selection of suitable biomarkers, detail currently available biosensor platforms including electrochemical, piezoelectric, magnetic, and optical sensors, and cover technology development for point-of-care biosensors for viral, bacterial, and parasitic infections. \u003c\/p\u003e\u003cp\u003e\u003ci\u003ePoint-of-Care Biosensors for Infectious Diseases\u003c\/i\u003e covers key topics such as: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eFundamentals of biosensor detection, with a focus on optical and electrochemical techniques\u003c\/li\u003e\n\u003cli\u003eOrganic and inorganic based nanomaterials for healthcare diagnostics\u003c\/li\u003e\n\u003cli\u003eStrategies for miniaturizing biosensor devices, and state-of-the-art integrated sensing platforms\u003c\/li\u003e\n\u003cli\u003eLatest trends in point-of-care biosensing systems to detect, diagnose, and monitor infectious diseases\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003eProviding comprehensive coverage of the subject, \u003ci\u003ePoint-of-Care Biosensors for Infectious Diseases\u003c\/i\u003e is an excellent reference for all developers, researchers, and technology managers in the areas of molecular diagnosis, infectious diseases, biosensors, and related fields.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Biosensors for Infectious Diseases-Fundamentals 1\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMaheswata Moharana, Subrat K. Pattanayak, Fahmida Khan, and Sushma Dave\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 1\u003c\/p\u003e \u003cp\u003e1.2 Biosensors Fundamental Aspects 2\u003c\/p\u003e \u003cp\u003e1.3 Classifications of Biosensor 3\u003c\/p\u003e \u003cp\u003e1.3.1 Biorecognition Perspective 3\u003c\/p\u003e \u003cp\u003e1.3.1.1 Nucleic Acid Biosensors 3\u003c\/p\u003e \u003cp\u003e1.3.1.2 Protein–Receptor Biosensor 5\u003c\/p\u003e \u003cp\u003e1.3.1.3 Enzymatic Biosensor 5\u003c\/p\u003e \u003cp\u003e1.3.1.4 Whole-Cells Biosensors 5\u003c\/p\u003e \u003cp\u003e1.3.1.5 Antibody-Based Biosensor 6\u003c\/p\u003e \u003cp\u003e1.4 Transduction Through Signals 6\u003c\/p\u003e \u003cp\u003e1.4.1 Electrochemical Biosensors 6\u003c\/p\u003e \u003cp\u003e1.4.2 Optical 6\u003c\/p\u003e \u003cp\u003e1.4.3 Thermometric (Calorimetric) 7\u003c\/p\u003e \u003cp\u003e1.4.4 Mass-Sensitive 7\u003c\/p\u003e \u003cp\u003e1.4.5 Electrical 8\u003c\/p\u003e \u003cp\u003e1.5 Conclusions 8\u003c\/p\u003e \u003cp\u003eReferences 9\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Nuts and Bolts of Modern Biosensing Technology: Smart Health Diagnostic Devices 15\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eItthipon Jeerapan, Gabriela Valdés-Ramírez, and Barbara Brunetti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 15\u003c\/p\u003e \u003cp\u003e2.2 Nuts and Bolts for Point-of-Care (POC) Biosensor-Based Testing 17\u003c\/p\u003e \u003cp\u003e2.2.1 Analytes 18\u003c\/p\u003e \u003cp\u003e2.2.2 Receptors and Sensing Elements 18\u003c\/p\u003e \u003cp\u003e2.2.3 Transducer 20\u003c\/p\u003e \u003cp\u003e2.2.4 Signal Processing Unit 21\u003c\/p\u003e \u003cp\u003e2.3 Advances in Biosensing Technology 21\u003c\/p\u003e \u003cp\u003e2.3.1 Advanced Sensors for Detecting Pathogens 21\u003c\/p\u003e \u003cp\u003e2.3.1.1 Biosensors for Bacteria Detection 22\u003c\/p\u003e \u003cp\u003e2.3.1.2 Biosensors for Detecting Viruses 26\u003c\/p\u003e \u003cp\u003e2.3.2 Advanced Biosensors for Monitoring Metabolites 33\u003c\/p\u003e \u003cp\u003e2.4 Conclusion and Prospects 40\u003c\/p\u003e \u003cp\u003eReferences 41\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Disease Related Detection with Electrochemical Biosensors 49\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAnulipsa Priyadarshini, Niharika Das, Saraswati Soren, Jashobanta Sahoo, Raghabendra Samantray, and Rojalin Sahu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 49\u003c\/p\u003e \u003cp\u003e3.2 Electrochemical Biosensors 50\u003c\/p\u003e \u003cp\u003e3.2.1 Materials 51\u003c\/p\u003e \u003cp\u003e3.2.2 Working Principle 53\u003c\/p\u003e \u003cp\u003e3.3 Immobilization of Different Biomolecules 54\u003c\/p\u003e \u003cp\u003e3.4 Different Types of Techniques Used in EC Biosensors for Detection of Various Diseases 55\u003c\/p\u003e \u003cp\u003e3.4.1 Voltametric Biosensor 55\u003c\/p\u003e \u003cp\u003e3.4.2 Electrochemical DNA Biosensors 56\u003c\/p\u003e \u003cp\u003e3.4.3 Impedance Biosensors 58\u003c\/p\u003e \u003cp\u003e3.4.4 Amperometric Biosensors 58\u003c\/p\u003e \u003cp\u003e3.4.5 Potentiometric Biosensors 60\u003c\/p\u003e \u003cp\u003e3.4.6 Electrochemical Immunosensor 61\u003c\/p\u003e \u003cp\u003e3.5 Conclusion and Future Direction 62\u003c\/p\u003e \u003cp\u003eReferences 63\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Biosensors for Point-of-Care (POC) Applications 69\u003cbr\u003e \u003c\/b\u003eThe Flag Bearer of the Modern Medicinal Technology to Tackle Infectious Diseases\u003cbr\u003e \u003ci\u003eSumit Kumar, Garima Rathee, Gaurav Bartwal, and Pratima R. Solanki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 69\u003c\/p\u003e \u003cp\u003e4.2 Classification of POC Biosensors for Detection of Infectious Diseases 71\u003c\/p\u003e \u003cp\u003e4.2.1 Electrochemical-Based Biosensor 71\u003c\/p\u003e \u003cp\u003e4.2.2 Fluorescence-Based Biosensor 72\u003c\/p\u003e \u003cp\u003e4.2.2.1 Direct Fluorescence Biosensors for Infectious Diseases 72\u003c\/p\u003e \u003cp\u003e4.2.2.2 Signal-on\/off Fluorescent Biosensors for Infectious Disease POC Diagnostics 73\u003c\/p\u003e \u003cp\u003e4.2.3 Surface Plasmon Resonance (SPR)-Based Biosensor 73\u003c\/p\u003e \u003cp\u003e4.2.4 Surface-Enhanced Raman Scattering (SERS)-Based Biosensor 73\u003c\/p\u003e \u003cp\u003e4.2.5 Chemiluminescence-Based Biosensor 74\u003c\/p\u003e \u003cp\u003e4.2.6 Colorimetric-Based Biosensors 74\u003c\/p\u003e \u003cp\u003e4.2.7 Magnetic-Based Biosensors 74\u003c\/p\u003e \u003cp\u003e4.3 Modern Devices for the Detection of Infectious Diseases 75\u003c\/p\u003e \u003cp\u003e4.3.1 Lab-on-a-Chip Devices and Lab-on-a-Disc Devices 75\u003c\/p\u003e \u003cp\u003e4.3.2 Microfluidic Paper-Based Analytical and Lateral Flow Devices 76\u003c\/p\u003e \u003cp\u003e4.3.3 Miniaturized PCR and Isothermal Nucleic Acid Amplification Devices 78\u003c\/p\u003e \u003cp\u003e4.4 Scope and Challenges Associated with the Next-Generation POC Devices 79\u003c\/p\u003e \u003cp\u003e4.5 Conclusion 79\u003c\/p\u003e \u003cp\u003eReferences 80\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Organic- and Inorganic-Based Nanomaterials for Healthcare Diagnostics 87\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eKomal Kashyap, Maheswata Moharana, Fahmida Khan, and Subrat K. Pattanayak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 87\u003c\/p\u003e \u003cp\u003e5.2 Nanomaterials Based on Carbon Allotropes in Healthcare 88\u003c\/p\u003e \u003cp\u003e5.3 Inorganic Nanomaterials in Health Diagnosis 91\u003c\/p\u003e \u003cp\u003e5.4 Organic Nanomaterials in Healthcare Diagnosis 92\u003c\/p\u003e \u003cp\u003e5.5 Future Prospects 95\u003c\/p\u003e \u003cp\u003eReferences 95\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 CRISPR\/Cas System 101\u003cbr\u003e \u003c\/b\u003eApplications in Diagnosis of Infectious Diseases\u003cbr\u003e \u003ci\u003eDeepak Kumar Sahel and Mohd Azhar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 101\u003c\/p\u003e \u003cp\u003e6.2 Nucleic Acids: Role in the Diagnosis 102\u003c\/p\u003e \u003cp\u003e6.2.1 Deoxyribonucleic Acids 103\u003c\/p\u003e \u003cp\u003e6.2.2 Ribonucleic Acids 103\u003c\/p\u003e \u003cp\u003e6.3 Nucleic Acid Biomarkers in Infectious Diseases 104\u003c\/p\u003e \u003cp\u003e6.4 Nucleic Acid Detection and Limitations 106\u003c\/p\u003e \u003cp\u003e6.5 CRISPR\/Cas System 108\u003c\/p\u003e \u003cp\u003e6.5.1 Characteristics Features of Different Cas Effectors 110\u003c\/p\u003e \u003cp\u003e6.5.2 CRISPR in Diagnostics 111\u003c\/p\u003e \u003cp\u003e6.5.2.1 Cas9-Based Detection 112\u003c\/p\u003e \u003cp\u003e6.5.2.2 Cas12-Based Detection 112\u003c\/p\u003e \u003cp\u003e6.5.2.3 Cas13-Based Detection 116\u003c\/p\u003e \u003cp\u003e6.5.2.4 Other Cas Effectors-Based Detection 117\u003c\/p\u003e \u003cp\u003e6.6 Conclusion and Prospects 119\u003c\/p\u003e \u003cp\u003eReferences 119\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Role of Piezoelectric Biosensors 129\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJaykishon Swain, Subrat Swain, Durgesh Singh, Anirudha Jena, Raghabendra Samantaray, and Rojalin Sahu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 129\u003c\/p\u003e \u003cp\u003e7.2 Types of Piezoelectric Biosensors 131\u003c\/p\u003e \u003cp\u003e7.2.1 Inorganic Piezoelectric Material 131\u003c\/p\u003e \u003cp\u003e7.2.2 Organic Piezoelectric Biosensors 133\u003c\/p\u003e \u003cp\u003e7.3 Application of Piezoelectric Biosensor Devices 135\u003c\/p\u003e \u003cp\u003e7.3.1 Immunosensors Based on Piezoelectric Material 135\u003c\/p\u003e \u003cp\u003e7.3.2 Piezoelectric Device with Molecularly Imprinted Polymers 137\u003c\/p\u003e \u003cp\u003e7.3.3 Piezoelectric Biosensors for Genetic Information 138\u003c\/p\u003e \u003cp\u003e7.4 Conclusion 139\u003c\/p\u003e \u003cp\u003eReferences 140\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Metal\/Metal Oxide Nanoparticles-Based Biosensors for Detection of Infectious Diseases 147\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eDipak Maity, Gajiram Murmu, Satya R. Sahoo, Ankur Tiwari, Siddharth Ajith, and Sumit Saha\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 147\u003c\/p\u003e \u003cp\u003e8.2 Biosensors 148\u003c\/p\u003e \u003cp\u003e8.2.1 Electrochemical Biosensors 148\u003c\/p\u003e \u003cp\u003e8.2.2 Colorimetric Biosensors 150\u003c\/p\u003e \u003cp\u003e8.2.3 Fluorescence Biosensors 151\u003c\/p\u003e \u003cp\u003e8.3 Types of Infectious Diseases 153\u003c\/p\u003e \u003cp\u003e8.4 Nanoparticles-Based Biosensors 156\u003c\/p\u003e \u003cp\u003e8.4.1 Recognition of Pathogens 157\u003c\/p\u003e \u003cp\u003e8.4.2 Metal\/Metal Oxide Nanoparticles-Based Biosensors 157\u003c\/p\u003e \u003cp\u003e8.4.2.1 Gold Nanoparticles 158\u003c\/p\u003e \u003cp\u003e8.4.2.2 Magnetic Nanoparticles 158\u003c\/p\u003e \u003cp\u003e8.4.2.3 Quantum Dots 159\u003c\/p\u003e \u003cp\u003e8.4.2.4 Other Metal\/Metal Oxide Nanoparticles 160\u003c\/p\u003e \u003cp\u003e8.5 Metal\/Metal Oxide Nanoparticles-Based Biosensors used for Infectious Diseases 160\u003c\/p\u003e \u003cp\u003e8.5.1 Gold Nanoparticles (AuNPs) 161\u003c\/p\u003e \u003cp\u003e8.5.2 Silver Nanoparticles (AgNPs) 163\u003c\/p\u003e \u003cp\u003e8.5.3 Platinum Nanoparticles (PtNPs) 164\u003c\/p\u003e \u003cp\u003e8.5.4 Copper Nanoparticles (CuNPs) 165\u003c\/p\u003e \u003cp\u003e8.5.5 Zinc Oxide Nanoparticles (ZnONPs) 166\u003c\/p\u003e \u003cp\u003e8.5.6 Miscellaneous Metal Oxide Nanoparticles 167\u003c\/p\u003e \u003cp\u003e8.6 Comparative Studies of Biosensors for Infectious Diseases: Advantages and Limitations 171\u003c\/p\u003e \u003cp\u003e8.6.1 Electrochemical Biosensors 171\u003c\/p\u003e \u003cp\u003e8.6.2 Fluorescence-Based Biosensors 172\u003c\/p\u003e \u003cp\u003e8.6.3 Colorimetric Biosensors 172\u003c\/p\u003e \u003cp\u003e8.7 Conclusion and Future Prospects 173\u003c\/p\u003e \u003cp\u003eAcknowledgment 174\u003c\/p\u003e \u003cp\u003eReferences 174\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Biosensors for Point-of-Care Applications: Replacing Pathology Labs by Bedside Devices 187\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMayukh Sinha, Sayak Banerjee, Sambit Majumdar, and Arindam Kushagra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 187\u003c\/p\u003e \u003cp\u003e9.2 POCT Relevance in Healthcare 187\u003c\/p\u003e \u003cp\u003e9.3 Self-Blood Glucose Monitoring 189\u003c\/p\u003e \u003cp\u003e9.3.1 Introduction 189\u003c\/p\u003e \u003cp\u003e9.3.2 Requirements for Self-Glucose Monitoring Device 189\u003c\/p\u003e \u003cp\u003e9.3.3 Types of Sensor-Based Monitoring System 189\u003c\/p\u003e \u003cp\u003e9.3.3.1 Continuous Glucose Monitoring (CGM) 189\u003c\/p\u003e \u003cp\u003e9.3.3.2 Flash Glucose Monitoring (FGM) 190\u003c\/p\u003e \u003cp\u003e9.4 Methods of Blood Glucose Monitoring 190\u003c\/p\u003e \u003cp\u003e9.4.1 Enzymatic Assay Reaction 190\u003c\/p\u003e \u003cp\u003e9.4.2 Detection Method 191\u003c\/p\u003e \u003cp\u003e9.4.3 Errors Occuring in Blood Glucose Monitoring 191\u003c\/p\u003e \u003cp\u003e9.4.4 POCT for Blood Glucose Monitoring 191\u003c\/p\u003e \u003cp\u003e9.5 Blood Gas Analysis 192\u003c\/p\u003e \u003cp\u003e9.5.1 Introduction 192\u003c\/p\u003e \u003cp\u003e9.5.2 Methodologies 192\u003c\/p\u003e \u003cp\u003e9.5.3 Electrochemical Sensors 192\u003c\/p\u003e \u003cp\u003e9.5.4 Optical Sensors 192\u003c\/p\u003e \u003cp\u003e9.5.5 Measurement of the Blood Gas Parameters 193\u003c\/p\u003e \u003cp\u003e9.5.6 pH 193\u003c\/p\u003e \u003cp\u003e9.5.7 PaCO\u003csub\u003e2\u003c\/sub\u003e 193\u003c\/p\u003e \u003cp\u003e9.5.8 PaO\u003csub\u003e2\u003c\/sub\u003e 194\u003c\/p\u003e \u003cp\u003e9.5.9 Glucose and Lactate Metabolites 195\u003c\/p\u003e \u003cp\u003e9.5.9.1 Electrolytes 196\u003c\/p\u003e \u003cp\u003e9.5.9.2 Hemoglobin, Bilirubin 196\u003c\/p\u003e \u003cp\u003e9.5.10 POCT of Blood Gas Analysis 197\u003c\/p\u003e \u003cp\u003e9.6 Urine Analysis 197\u003c\/p\u003e \u003cp\u003e9.6.1 Introduction 197\u003c\/p\u003e \u003cp\u003e9.6.2 Methodologies 198\u003c\/p\u003e \u003cp\u003e9.6.2.1 Urine Dipsticks (Colorimetric Reagent Strip) 198\u003c\/p\u003e \u003cp\u003e9.6.2.2 Lateral Flow Immunoassay (Rapid Test) 198\u003c\/p\u003e \u003cp\u003e9.6.3 Measurement of the Parameters in the Urine Sample 200\u003c\/p\u003e \u003cp\u003e9.6.3.1 Protein 200\u003c\/p\u003e \u003cp\u003e9.6.3.2 Nitrite 201\u003c\/p\u003e \u003cp\u003e9.6.3.3 Leukocytes 201\u003c\/p\u003e \u003cp\u003e9.6.3.4 Bilirubin 201\u003c\/p\u003e \u003cp\u003e9.6.3.5 Urobilinogen 202\u003c\/p\u003e \u003cp\u003e9.6.3.6 Specific Gravity 202\u003c\/p\u003e \u003cp\u003e9.6.3.7 Hemoglobin (Hb) 203\u003c\/p\u003e \u003cp\u003e9.6.3.8 Ketone 203\u003c\/p\u003e \u003cp\u003e9.6.3.9 pH 203\u003c\/p\u003e \u003cp\u003e9.6.3.10 Glucose 203\u003c\/p\u003e \u003cp\u003e9.7 Conclusion 204\u003c\/p\u003e \u003cp\u003eReferences 204\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Strategic Synthesis of Diagnostic Novel Materials Against Infectious Diseases 209\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eHardik Shyam Churi and Sushma Dave\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 209\u003c\/p\u003e \u003cp\u003e10.2 Detection Needs at the POC 211\u003c\/p\u003e \u003cp\u003e10.2.1 Nanomaterials for Malaria Parasites Detection 212\u003c\/p\u003e \u003cp\u003e10.2.2 Nanomaterials for HIV 214\u003c\/p\u003e \u003cp\u003e10.2.3 Nanomaterials for HBV 215\u003c\/p\u003e \u003cp\u003e10.2.4 Nanomaterials for HPV 216\u003c\/p\u003e \u003cp\u003e10.2.5 Nanomaterials for Dengue Virus 217\u003c\/p\u003e \u003cp\u003e10.2.6 Nanomaterials for Ebola Virus 217\u003c\/p\u003e \u003cp\u003e10.2.7 Nanomaterials for Mycobacterium Tuberculosis 218\u003c\/p\u003e \u003cp\u003e10.2.8 Nanomaterials for Zika Virus 219\u003c\/p\u003e \u003cp\u003e10.2.9 Nanomaterials for Biomarkers in Infectious Disease POCT 220\u003c\/p\u003e \u003cp\u003e10.2.10 Nanomaterials for Pathogen Nucleic Acids 221\u003c\/p\u003e \u003cp\u003e10.2.11 Nanomaterials for Antibodies and Proteins 222\u003c\/p\u003e \u003cp\u003e10.3 Technology Advancements in Infectious Disease POCT 224\u003c\/p\u003e \u003cp\u003e10.4 Futuristic Developments 224\u003c\/p\u003e \u003cp\u003eReferences 225\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Development of a Diagnostic Kit for Point-of-Care Biosensors: Fundamentals and Applications 235\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eVijay Vaishampayan, Prabir Kulabhushan, Ishita Dasgupta, Ashish Kapoor, and Sarang P. Gumfekar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 235\u003c\/p\u003e \u003cp\u003e11.2 Evolution of Biosensor 236\u003c\/p\u003e \u003cp\u003e11.3 Biosensors for Point-of-Care Sensing 237\u003c\/p\u003e \u003cp\u003e11.3.1 Fundamentals of Biosensor 237\u003c\/p\u003e \u003cp\u003e11.3.2 Bioreceptors in Biosensor 238\u003c\/p\u003e \u003cp\u003e11.3.3 Transducer in Biosensor 240\u003c\/p\u003e \u003cp\u003e11.3.3.1 Electrochemical Biosensor 240\u003c\/p\u003e \u003cp\u003e11.3.3.2 Potentiometric Biosensor 241\u003c\/p\u003e \u003cp\u003e11.3.3.3 Amperometric Biosensor 241\u003c\/p\u003e \u003cp\u003e11.3.3.4 Impedimetric Biosensors 241\u003c\/p\u003e \u003cp\u003e11.3.3.5 Voltammetric Biosensors 241\u003c\/p\u003e \u003cp\u003e11.3.3.6 Optical Biosensor 241\u003c\/p\u003e \u003cp\u003e11.3.3.7 Gravimetric Biosensor 241\u003c\/p\u003e \u003cp\u003e11.3.3.8 Acoustic Biosensors 243\u003c\/p\u003e \u003cp\u003e11.3.4 Materials Used to Fabricate Biosensors 243\u003c\/p\u003e \u003cp\u003e11.3.5 Biosensors for Infectious Diseases 243\u003c\/p\u003e \u003cp\u003e11.3.6 Biosensor for the Detection of Dengue 243\u003c\/p\u003e \u003cp\u003e11.3.7 Biosensors for Tuberculosis 246\u003c\/p\u003e \u003cp\u003e11.3.8 Future Scope 246\u003c\/p\u003e \u003cp\u003e11.4 Conclusion 247\u003c\/p\u003e \u003cp\u003eAcknowledgment 248\u003c\/p\u003e \u003cp\u003eReferences 248\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Lab-on-a-Chip Devices for Point-of-Care Infectious Diseases Diagnostics 255\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eSnehal Jani, Vishakha Dave, Medha Pandya, Ranjeet Brajpuriya, and Sushma Dave\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 255\u003c\/p\u003e \u003cp\u003e12.2 Design of Lab-on-a-Chip Devices 257\u003c\/p\u003e \u003cp\u003e12.2.1 Microfluidic Paper-Based Analytical Devices (μPADs) 258\u003c\/p\u003e \u003cp\u003e12.2.1.1 Fabrication of Paper-Based Microfluidic Devices 259\u003c\/p\u003e \u003cp\u003e12.2.2 Chip-Based Microfluidic LOCs 261\u003c\/p\u003e \u003cp\u003e12.2.3 Chip-Based Microfluidic Device Substrate Materials 262\u003c\/p\u003e \u003cp\u003e12.2.4 Fundamentals of Flow of Liquid in Microchannels 262\u003c\/p\u003e \u003cp\u003e12.2.5 Sampling 263\u003c\/p\u003e \u003cp\u003e12.2.6 Diagnostics Material\/Biomarkers in Microfluidic Devices 263\u003c\/p\u003e \u003cp\u003e12.2.7 Signal Generation and Detection 264\u003c\/p\u003e \u003cp\u003e12.2.7.1 Electrochemical Method 264\u003c\/p\u003e \u003cp\u003e12.2.7.2 Magnetic Particle Labeling 265\u003c\/p\u003e \u003cp\u003e12.2.7.3 Optical Detection 265\u003c\/p\u003e \u003cp\u003e12.3 LOC for Diagnosis of Infectious Diseases 266\u003c\/p\u003e \u003cp\u003e12.3.1 LOC for Virus Detection 266\u003c\/p\u003e \u003cp\u003e12.3.2 LOC for Detection of Bacteria 267\u003c\/p\u003e \u003cp\u003e12.3.2.1 Future Perspectives and Conclusion 268\u003c\/p\u003e \u003cp\u003eReferences 270\u003c\/p\u003e \u003cp\u003eIndex 275\u003c\/p\u003e","brand":"Wiley-VCH Verlag GmbH","offers":[{"title":"Default Title","offer_id":48743126303063,"sku":"9783527350452","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"health-physics-radiation-generating-devices-characteristics-and-hazards-9783527411833","title":"Health Physics: Radiation-Generating Devices, Characteristics, and Hazards","description":"\u003cp\u003eThe book bridges the gap between existing health physics textbooks and reference material needed by a practicing health physicist as the 21st century progresses. This material necessarily encompasses emerging radiation-generating technologies, advances in existing technology, and applications of existing technology to new areas. The book is written for advanced undergraduate and graduate science and engineering courses. It is also be a useful reference for scientists and engineers.\u003c\/p\u003e","brand":"Wiley-VCH Verlag GmbH","offers":[{"title":"Default Title","offer_id":48743127384407,"sku":"9783527411832","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"chemistry-of-renewables-an-introduction-9783662614297","title":"Chemistry of Renewables: An Introduction","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThis textbook introduces the industrial production and processing of natural resources. It is divided into six major topics (fats and oils, carbohydrates, lignin, terpenoids, other natural products, biorefinery), which are divided into a total of 20 chapters.\u003c\/p\u003e\u003cp\u003eEach chapter is self-contained and therefore a compact learning unit, which can be worked on by students in self-study or presented by lecturers. Clear illustrations, flow diagrams, apparatus drawings and photos facilitate the understanding of the subject matter. All chapters end with a succinct summary, the \"Take Home Messages\". Each chapter is supplemented by ten short test questions, which can be solved quickly after working through the chapter; the answers are at the end of the book. All chapters contain bibliographical references that focus on essential textbooks and reference works. As a prior knowledge, only basic knowledge of chemistry is required. \u003cbr\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e1 Overview\/Introduction.- I Fats and Oils.- 2 Plant Oils.- 3 Fat Products\/Oleochemicals.- 4 Reactions of fatty acid chains\/Special Oleochemical Products.- 5 The by-product of Oleochemistry\/Glycerol.- II Carbohydrate.- 6 Sugar Chemistry.- 7 From wood to pulp\/Cellulose.- 8 Starch Chemistry.- 9 Carbohydrates from the sea.- 10 Cyclodextrins.- III Lignin.- 11 Woods' essential ingredient\/Lignin.- IV Terpenoids.- 12 Tree Balm\/Terpenes.- 13 Natural rubber and its processing.- V Other Natural Products.- 14 Building blocks of life\/Amino acids and proteins.- 15 Natural Dyes.- 16 Natural Pharmaceuticals.- 17 The essential 'amines'.- 18 Natural Fragrances and Flavours.- 19 Plastics from nature\/Biopolymers.- VI Biorefineries.- 20 Smart raw materials.- Answers to the 'Quickies'.- Index.\u003cp\u003e\u003c\/p\u003e","brand":"Springer-Verlag Berlin and Heidelberg GmbH \u0026 Co. KG","offers":[{"title":"Default Title","offer_id":48743142621527,"sku":"9783662614297","price":59.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9783662614297.jpg?v=1720064297"},{"product_id":"applied-rna-bioscience-9789811083716","title":"Applied RNA Bioscience","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThe focus of this book is to introduce up-to-date information on applications and practical use of RNA for agriculture, biotechnology and medicine. It provides unique ideas, tools, and methods in detail from a variety of scientific and technical disciplines.  RNA science has progressed enormously in recent decades, and vast amounts of information on RNA functions and their regulatory mechanisms are becoming available. Such a progress opened the door to an age of practical application of RNA in many fields including agriculture, plant science, medical science, brewing and fermentation technology, and material production. This book inspires its readership and contributes to not only expansion in application of RNA but also to basic research. \u003cbr\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eList of titles and authors (as of 24 Aug 2016)\u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e1. Gene expression system that can escape from translational repression caused by brewing-related stress\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Shingo IZAWA\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e2. Bacterial cellular engineering through interspecies exchange of 16S rRNA in \u003ci\u003eEscherichia coli \u003c\/i\u003eribosome.\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Kentaro MIYAZAKI\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e3. Development and application of the excellent protein synthesis technique with riboswitches in microorganisms\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Takahiro YAMAUCHI and Naoki SUGIMOTO\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e4. Cell Reprogramming by Lactic Acid Bacteria.\u003c\/b\u003e\u003c\/p\u003e    Kunimasa OHTA\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e5. \u003c\/b\u003e\u003cb\u003eNovel detection system of mycotoxin using aptamer\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Yuji MORITA\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e6. \u003c\/b\u003e\u003cb\u003eRational design of artificial riboswitches\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Atsushi OGAWA\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e7. mRNA engineering as a tool for controlling mammalian cells in medical applications\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Kei ENDO and Hirohide SAITO\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e8. \u003c\/b\u003e\u003cb\u003eModulation of abnormal splicing by small chemical compounds in RNA diseases\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Naoyuki KATAOKA\u003c\/p\u003e  \u003cb\u003e \u003c\/b\u003e\u003cb\u003e9. Protein production system by innovating mRNA export\u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e  Seiji MASUDA\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e10. PPR protein and the engineering\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Takahiro NAKAMURA\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e11. Long noncoding RNAs and their applications\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e  Tomohiro YAMAZAKI \u003c\/p\u003e  \u003cp\u003e \u003cb\u003e12\u003c\/b\u003e. \u003cb\u003eLong non-coding RNA as new diagnostic and therapeutic targets\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e   Eleonora LEUCCI\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e13. Riboswitches and ribozymes as RNA-based modular tools to control gene expression\u003c\/b\u003e\u003c\/p\u003e  \u003cp\u003e   Yoshiya IKAWA and Shigeyoshi Matsumura\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e14.\u003c\/b\u003e\u003cb\u003e Applications of CRISPR\/Cas9 genome editing for functional characterization of RNA helicases\u003c\/b\u003e\u003c\/p\u003e     Jerry PELLETIER\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e \u003cb\u003e15. Application of systemic TGS on p\u003c\/b\u003e\u003c\/p\u003elant breeding\u003cp\u003e\u003c\/p\u003e  \u003cp\u003e   Songling BAI\u003c\/p\u003e  \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003cb\u003e16. Theoretical and applied epigenetics in plants\u003c\/b\u003e\u003c\/p\u003e     Yuhya WAKASA, Taiji KAWAKATSU, and Fumio TAKAIWA","brand":"Springer Verlag, Singapore","offers":[{"title":"Default Title","offer_id":48743275168087,"sku":"9789811083716","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"a-practical-guide-to-pharmacological-biotechnology-9789811363542","title":"A Practical Guide to Pharmacological","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003ePharmacological biotechnology is applied to and used to study drug development, working mechanisms, diagnosis, and therapies. This textbook covers the whole range of experiments related to pharmacology. It also contains basic laboratory safety guidelines along with the basic calculations and formulas used in a laboratory. Each chapter starts with an introduction\/theory into the basic approach followed by detailed methods sections with easy-to-follow protocols and comprehensive troubleshooting, calculations and possible questions for examination. The target group is researchers who are studying pharmacological biotechnology in the laboratory.\u003cp\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePart1.Introduction.- 1.1 Rules of laboratory safety in a pharmacology laboratory.- 1.2 Commom instruments and their uses used in a pharmacology laboratory.- Part2.General aspects of Pharmacology laboratory.- 2.1 Safety and Risk assessment.- 2.2 Use and Handling of laboratory animals.- 2.3 Experimental design.- 2.4 Essential statistics.- 2.5 Cumulative Dose Response Curve.- 2.6 Toxicology.- 2.7 Basic instruments and techniques in Pharmacology Laboratory .- Part3.Isolated tissues and organs.- 3.1 Basic instruments used for isolated tissue experiments.- 3.2 Organ baths.- 3.3 Smooth muscle preparations.- 3.4 Skeletal muscle preparations.- 3.5 Cardiac muscle preparations.- Part4.Isolated tissues for screening of drugs.- 4.1 Evaluation of antidiabetic agents.- 4.2 Evaluation of antidepressants.- 4.3 Evaluation of antihypertensive agents.- 4.4 Evaluation of antiulcer agents.- 4.5 Evaluation of hepatotoxicity.- 4.6 Evaluation of Antioxidant agents.- 4.7 Evaluation of local anaesthetics.- Part5.Genotoxicity and Toxicological studies.- 5.1 The Mouse Lymphoma Assay.- 5.2 The Comet Assay.- 5.3 In vitro Genotoxicity assay.- 5.4 In vitro Teratogenicity Testing.- 5.5 Histopathological studies of animal tissues.- 5.6 Drug poisoning.-  Part6.Experimental Animal studies.- 6.1 Pyrogen testing.- 6.2 Collecting blood from mice.- 6.3 Studies on different parameters of blood.- 6.4 Experiment on central nervous system.- 6.5 Evaluation on cardiovascular system.- 6.6 Experiments on GI tract.- Part7.Clinical trials.- 7.1 Clinical Pharmacology and its genesis.- 7.2 National and International agencies and their role in Clinical pharmacology.- 7.3 Stages in drug development and clinical trials.- 7.4 Ethics in Clinical research.- 7.5 Safety assessment in Clinical trials.- Part8.IPR and ethics in animal studies.- 8.1 Intellectual property rights and its different categories.- 8.2 Importance of IPR in drug development.- 8.3 Patenting cells, cell lines and animals.- 8.4 Ethics in laboratory animal studies .-  8.5 Risk assessment and management.- 8.6 Good laboratory practices.","brand":"Springer Verlag, Singapore","offers":[{"title":"Default Title","offer_id":48743288078679,"sku":"9789811363542","price":999.99,"currency_code":"GBP","in_stock":false}]},{"product_id":"biomimicry-innovation-inspired-by-nature-9780060533229","title":"Biomimicry Innovation Inspired by Nature","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"HarperCollins","offers":[{"title":"Default Title","offer_id":48864043925847,"sku":"9780060533229","price":16.14,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780060533229.jpg?v=1722270129"},{"product_id":"programmable-planet-9780231205108","title":"Programmable Planet","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eProgrammable Planet\u003c\/i\u003e is a grand tour through the world of synthetic biology, telling the stories of the colorful visionaries whose ideas are shaping discoveries. Ted Anton explores the field from its beginning in fighting malaria in Africa to the COVID vaccines and beyond.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eProgrammable Planet\u003c\/i\u003e captures the passion and energy of those at the genesis of the construction of the genetically engineered world. -- Christopher Voigt, Daniel I.C. Wang Professor of Biological Engineering, Massachusetts Institute of Technology\u003cbr\u003eIf you’ve ever wondered about the promise—and the peril—of synthetic biology and its power to transform life, then \u003ci\u003eProgrammable Planet\u003c\/i\u003e is the book for you. Ted Anton’s exploration of both the history and the future of the ways we engineer life is incisive, engaging, and downright fascinating. -- Deborah Blum, Pulitzer Prize–winning author of \u003ci\u003eThe Poison Squad: One Chemist’s Single-Minded Crusade for Food Safety in the Early Twentieth Century\u003c\/i\u003e\u003cbr\u003e\u003ci\u003eProgrammable Planet\u003c\/i\u003e is a thoroughly engaging and enjoyable read. Anton is an expert storyteller who blends the human element with cutting-edge science like a synthetic biologist engineering a novel organism. Timely and at times provocative, the book provides a wonderful grounding for those interested in learning more about synthetic biology’s promise and threat. And we should all be interested in learning more. -- Aoife Brennan, president and chief executive officer, Synlogic\u003cbr\u003eIn this rollicking compendium, Anton documents a huge number of ways synthetic biology can be used in practice, embedding these examples in the experiences of the people involved. -- Drew Endy, Stanford University\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eIntroduction\u003cbr\u003e\u003cb\u003ePart I. Beginnings\u003c\/b\u003e\u003cbr\u003e1. A Glass of Absinthe: A Malaria Medicine\u003cbr\u003e2. A Radical Philosophy\u003cbr\u003e3. Pandora’s Box: The Triumph and Temptation of Gene Editing\u003cbr\u003e4. The Silk Road: Directing Evolution\u003cbr\u003e5. Wild: Remaking Life\u003cbr\u003e\u003cb\u003ePart II. Ripples in the Water\u003c\/b\u003e\u003cbr\u003e6. Rush: Biology-Made Medicines\u003cbr\u003e7. New Nature: A Do-It-Yourself Environment\u003cbr\u003e8. Hearth and Home\u003cbr\u003e9. Fantastic Voyages: Mining and the Military\u003cbr\u003e10. The Killers: Viruses as Healers\u003cbr\u003e\u003cb\u003ePart III. Bioindustrial Revolution\u003c\/b\u003e\u003cbr\u003e11. Race to a Vaccine\u003cbr\u003e12. Global Production: Perils and Profits of a New Science\u003cbr\u003e13. The Moirai’s Gift\u003cbr\u003e14. To the Planets, and Beyond: Synthetic Biology in Space\u003cbr\u003e15. Futurama\u003cbr\u003eAcknowledgments\u003cbr\u003eTimeline\u003cbr\u003eGlossary\u003cbr\u003eFurther Reading\u003cbr\u003eNotes\u003cbr\u003eIndex","brand":"Columbia University Press","offers":[{"title":"Default Title","offer_id":48864263471447,"sku":"9780231205108","price":28.5,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780231205108.jpg?v=1722271133"},{"product_id":"bad-blood-9780525431992","title":"Bad Blood","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003e\u003cb\u003e\u003cb\u003e\u003cb\u003e\u003cb\u003eNATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and T\u003cb\u003eheranos\u003cb\u003e—\u003c\/b\u003e\u003c\/b\u003eone of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close.\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —\u003ci\u003eThe New York Times Book Review\u003c\/i\u003e\u003c\/b\u003e\u003c\/b\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/b\u003e\u003cbr\u003eIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.","brand":"Random House USA Inc","offers":[{"title":"Default Title","offer_id":48864981746007,"sku":"9780525431992","price":11.05,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780525431992.jpg?v=1722273391"},{"product_id":"human-compatible-9780525558637","title":"Human Compatible","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eA leading artificial intelligence researcher lays out a new approach to AI that will enable us to coexist successfully with increasingly intelligent machines\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003eIn the popular imagination, superhuman artificial intelligence is an approaching tidal wave that threatens not just jobs and human relationships, but civilization itself. Conflict between humans and machines is seen as inevitable and its outcome all too predictable.\u003cbr\u003e\u003cbr\u003eIn this groundbreaking book, distinguished AI researcher Stuart Russell argues that this scenario can be avoided, but only if we rethink AI from the ground up. Russell begins by exploring the idea of intelligence in humans and in machines. He describes the near-term benefits we can expect, from intelligent personal assistants to vastly accelerated scientific research, and outlines the AI breakthroughs that still have to happen before we reach superhuman AI. He also spells out the ways humans are already finding to misuse AI, from lethal autonomous weapons to viral sabotage.\u003cbr\u003e\u003cbr\u003eIf the predicted breakthroughs occur and superhuman AI emerges, we will have created entities far more powerful than ourselves. How can we ensure they never, ever, have power over us?  Russell suggests that we can rebuild AI on a new foundation, according to which machines are designed to be inherently uncertain about the human preferences they are required to satisfy. Such machines would be humble, altruistic, and committed to pursue our objectives, not theirs. This new foundation would allow us to create machines that are provably deferential and provably beneficial.","brand":"Penguin Putnam Inc","offers":[{"title":"Default Title","offer_id":48864997867863,"sku":"9780525558637","price":15.2,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780525558637.jpg?v=1722273410"},{"product_id":"telehealthcare-9781119841760","title":"TeleHealthcare","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Machine Learning–Assisted Remote Patient Monitoring with Data Analytics 1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eVinutha D. C., Kavyashree and G. T. Raju\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 2\u003c\/p\u003e \u003cp\u003e1.1.1 Traditional Patient Monitoring System 2\u003c\/p\u003e \u003cp\u003e1.1.2 Remote Monitoring System 3\u003c\/p\u003e \u003cp\u003e1.1.3 Challenges in RPM 4\u003c\/p\u003e \u003cp\u003e1.2 Literature Survey 5\u003c\/p\u003e \u003cp\u003e1.2.1 Machine Learning Approaches in Patient Monitoring 7\u003c\/p\u003e \u003cp\u003e1.3 Machine Learning in RPM 8\u003c\/p\u003e \u003cp\u003e1.3.1 Support Vector Machine 9\u003c\/p\u003e \u003cp\u003e1.3.2 Decision Tree 10\u003c\/p\u003e \u003cp\u003e1.3.3 Random Forest 11\u003c\/p\u003e \u003cp\u003e1.3.4 Logistic Regression 11\u003c\/p\u003e \u003cp\u003e1.3.5 Genetic Algorithm 12\u003c\/p\u003e \u003cp\u003e1.3.6 Simple Linear Regression 12\u003c\/p\u003e \u003cp\u003e1.3.7 KNN Algorithm 13\u003c\/p\u003e \u003cp\u003e1.3.8 Naive Bayes Algorithm 14\u003c\/p\u003e \u003cp\u003e1.4 System Architecture 15\u003c\/p\u003e \u003cp\u003e1.4.1 Data Collection 16\u003c\/p\u003e \u003cp\u003e1.4.2 Data Pre-Processing 17\u003c\/p\u003e \u003cp\u003e1.4.3 Apply Machine Learning Algorithm and Prediction 18\u003c\/p\u003e \u003cp\u003e1.5 Results 21\u003c\/p\u003e \u003cp\u003e1.6 Future Enhancement 23\u003c\/p\u003e \u003cp\u003e1.7 Conclusion 24\u003c\/p\u003e \u003cp\u003eReferences 24\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 A Survey on Recent Computer-Aided Diagnosis for Detecting Diabetic Retinopathy 27\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePriyadharsini C., Jagadeesh Kannan R. and Farookh Khadeer Hussain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 28\u003c\/p\u003e \u003cp\u003e2.2 Diabetic Retinopathy 28\u003c\/p\u003e \u003cp\u003e2.2.1 Features of DR 28\u003c\/p\u003e \u003cp\u003e2.2.2 Stages of DR 29\u003c\/p\u003e \u003cp\u003e2.3 Overview of DL Models 31\u003c\/p\u003e \u003cp\u003e2.3.1 Convolution Neural Network 31\u003c\/p\u003e \u003cp\u003e2.3.2 Autoencoders 32\u003c\/p\u003e \u003cp\u003e2.3.3 Boltzmann Machine and Deep Belief Network 32\u003c\/p\u003e \u003cp\u003e2.4 Data Set 33\u003c\/p\u003e \u003cp\u003e2.5 Performance Metrics 34\u003c\/p\u003e \u003cp\u003e2.6 Literature Survey 36\u003c\/p\u003e \u003cp\u003e2.6.1 Segmentation of Blood Vessels 36\u003c\/p\u003e \u003cp\u003e2.6.2 Optic Disc Feature 49\u003c\/p\u003e \u003cp\u003e2.6.3 Lesion Detections 50\u003c\/p\u003e \u003cp\u003e2.6.3.1 Exudate Detection 50\u003c\/p\u003e \u003cp\u003e2.6.3.2 MA and HM 51\u003c\/p\u003e \u003cp\u003e2.6.4 DR Classification 51\u003c\/p\u003e \u003cp\u003e2.7 Discussion and Future Directions 52\u003c\/p\u003e \u003cp\u003e2.8 Conclusion 53\u003c\/p\u003e \u003cp\u003eReferences 53\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 A New Improved Cryptography Method-Based e-Health Application in Cloud Computing Environment 59\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDipesh Kumar, Nirupama Mandal and Yugal Kumar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 60\u003c\/p\u003e \u003cp\u003e3.1.1 Contribution 61\u003c\/p\u003e \u003cp\u003e3.2 Motivation 62\u003c\/p\u003e \u003cp\u003e3.3 Related Works 62\u003c\/p\u003e \u003cp\u003e3.4 Challenges 64\u003c\/p\u003e \u003cp\u003e3.5 Proposed Work 64\u003c\/p\u003e \u003cp\u003e3.6 Proposed Algorithm for Encryption 66\u003c\/p\u003e \u003cp\u003e3.6.1 Demonstration of Encryption Algorithm 66\u003c\/p\u003e \u003cp\u003e3.6.1.1 When the Number of Columns Selected in the Table is Even 66\u003c\/p\u003e \u003cp\u003e3.6.1.2 When the Number of Columns Selected in the Table is Odd 69\u003c\/p\u003e \u003cp\u003e3.6.2 Flowchart for Encryption 72\u003c\/p\u003e \u003cp\u003e3.7 Algorithm for Decryption 73\u003c\/p\u003e \u003cp\u003e3.7.1 Demonstration of Decryption Algorithm 73\u003c\/p\u003e \u003cp\u003e3.7.1.1 When the Number of Columns Selected in the Table is Even 73\u003c\/p\u003e \u003cp\u003e3.7.1.2 When the Number of Columns Selected in the Table is Odd 75\u003c\/p\u003e \u003cp\u003e3.7.2 Flowchart of Decryption Algorithm 78\u003c\/p\u003e \u003cp\u003e3.8 Experiment and Result 78\u003c\/p\u003e \u003cp\u003e3.9 Conclusion 80\u003c\/p\u003e \u003cp\u003eReferences 80\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Cutaneous Disease Optimization Using Teledermatology Underresourced Clinics 85\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSupriya M., Murugan K., Shanmugaraja T. and Venkatesh T.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 86\u003c\/p\u003e \u003cp\u003e4.2 Materials and Methods 87\u003c\/p\u003e \u003cp\u003e4.2.1 Clinical Setting and Teledermatology Workflow 87\u003c\/p\u003e \u003cp\u003e4.2.2 Study Design, Data Collection, and Analysis 87\u003c\/p\u003e \u003cp\u003e4.3 Proposed System 88\u003c\/p\u003e \u003cp\u003e4.3.1 Teledermatology in an Underresourced Clinic 88\u003c\/p\u003e \u003cp\u003e4.3.2 Teledermatology Consultations from Uninsured Patients 89\u003c\/p\u003e \u003cp\u003e4.3.3 Teledermatology for Patients Lacking Access to Dermatologists 90\u003c\/p\u003e \u003cp\u003e4.3.4 Teledermatologist Management from Nonspecialists 92\u003c\/p\u003e \u003cp\u003e4.3.5 Segment Factors of Referring PCPs and Their Patients 93\u003c\/p\u003e \u003cp\u003e4.3.6 Teledermatology Operational Considerations 94\u003c\/p\u003e \u003cp\u003e4.3.7 Instruction of PCPs 94\u003c\/p\u003e \u003cp\u003e4.4 Challenges 95\u003c\/p\u003e \u003cp\u003e4.5 Results and Discussion 95\u003c\/p\u003e \u003cp\u003e4.5.1 Challenges of Referring to Teledermatology Services 96\u003c\/p\u003e \u003cp\u003eReferences 98\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Cognitive Assessment Based on Eye Tracking Using Device-Embedded Cameras via Tele-Neuropsychology 101\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShanmugaraja T., Venkatesh T., Supriya M. and Murugan K.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 102\u003c\/p\u003e \u003cp\u003e5.2 Materials and Methods 102\u003c\/p\u003e \u003cp\u003e5.3 Framework Elements 102\u003c\/p\u003e \u003cp\u003e5.3.1 Eye Tracker Camera 102\u003c\/p\u003e \u003cp\u003e5.3.2 Test Construction 103\u003c\/p\u003e \u003cp\u003e5.3.3 Web Camera 106\u003c\/p\u003e \u003cp\u003e5.3.4 Camera for Eye Tracking 106\u003c\/p\u003e \u003cp\u003e5.4 Proposed System 106\u003c\/p\u003e \u003cp\u003e5.4.1 Camera for Tracking Eye 106\u003c\/p\u003e \u003cp\u003e5.4.2 Web Camera 108\u003c\/p\u003e \u003cp\u003e5.4.3 Scoring 108\u003c\/p\u003e \u003cp\u003e5.4.4 Eye Tracking Camera 108\u003c\/p\u003e \u003cp\u003e5.4.5 Web Camera Human-Coded Scoring 108\u003c\/p\u003e \u003cp\u003e5.5 Subjects 109\u003c\/p\u003e \u003cp\u003e5.5.1 Characteristics of Subject 109\u003c\/p\u003e \u003cp\u003e5.6 Methodology 110\u003c\/p\u003e \u003cp\u003e5.6.1 Analysis of Data 110\u003c\/p\u003e \u003cp\u003e5.7 Results 110\u003c\/p\u003e \u003cp\u003e5.8 Discussion 112\u003c\/p\u003e \u003cp\u003e5.9 Conclusion 114\u003c\/p\u003e \u003cp\u003eReferences 115\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Fuzzy-Based Patient Health Monitoring System 117\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eVenkatesh T., Murugan K., Supriya M., Shanmugaraja T. and Rekha Chakravarthi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 118\u003c\/p\u003e \u003cp\u003e6.1.1 General Problem 119\u003c\/p\u003e \u003cp\u003e6.1.2 Existing Patient Monitoring and Diagnosis Systems 119\u003c\/p\u003e \u003cp\u003e6.1.3 Fuzzy Logic Systems 120\u003c\/p\u003e \u003cp\u003e6.2 System Design 122\u003c\/p\u003e \u003cp\u003e6.2.1 Hardware Requirements 122\u003c\/p\u003e \u003cp\u003e6.2.1.1 Functional Requirements 123\u003c\/p\u003e \u003cp\u003e6.2.1.2 Nonfunctional Specifications 125\u003c\/p\u003e \u003cp\u003e6.3 Software Architecture 125\u003c\/p\u003e \u003cp\u003e6.3.1 The Data Acquisition Unit (DAQ) Application Programmable Interface (API) 126\u003c\/p\u003e \u003cp\u003e6.3.2 Flowchart—API 128\u003c\/p\u003e \u003cp\u003e6.3.3 Foreign Tag IDs 129\u003c\/p\u003e \u003cp\u003e6.3.4 Database Manager 130\u003c\/p\u003e \u003cp\u003e6.3.5 Database Designing 130\u003c\/p\u003e \u003cp\u003e6.3.6 The Fuzzy Logic System 131\u003c\/p\u003e \u003cp\u003e6.3.6.1 Introduction to Fuzzy Logic 131\u003c\/p\u003e \u003cp\u003e6.3.6.2 The Modified Prior Alerting Score (MPAS) 132\u003c\/p\u003e \u003cp\u003e6.3.6.3 Structure of the Fuzzy Logic System 134\u003c\/p\u003e \u003cp\u003e6.3.7 Designing a System in Fuzzy 135\u003c\/p\u003e \u003cp\u003e6.3.7.1 Input Variables 135\u003c\/p\u003e \u003cp\u003e6.3.7.2 The Output Variable 138\u003c\/p\u003e \u003cp\u003e6.4 Results and Discussion 140\u003c\/p\u003e \u003cp\u003e6.4.1 Hardware Sensors Validation 140\u003c\/p\u003e \u003cp\u003e6.4.2 Implementations, Testing, and Evaluation of the Fuzzy Logic Engine 141\u003c\/p\u003e \u003cp\u003e6.4.3 Normal Group (NRM) 146\u003c\/p\u003e \u003cp\u003e6.4.4 Low Risk Group 146\u003c\/p\u003e \u003cp\u003e6.4.5 High Risk Group (HRG) 153\u003c\/p\u003e \u003cp\u003e6.5 Conclusions and Future Work 155\u003c\/p\u003e \u003cp\u003e6.5.1 Summary and Concluding Remarks 155\u003c\/p\u003e \u003cp\u003e6.5.2 Future Directions 155\u003c\/p\u003e \u003cp\u003eReferences 155\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Artificial Intelligence: A Key for Detecting COVID-19 Using Chest Radiography 159\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eC. Vinothini, P. Anitha, Priya J., Abirami A. and Akash S.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 160\u003c\/p\u003e \u003cp\u003e7.2 Related Work 162\u003c\/p\u003e \u003cp\u003e7.2.1 Traditional Approach 162\u003c\/p\u003e \u003cp\u003e7.2.2 Deep Learning–Based Approach 163\u003c\/p\u003e \u003cp\u003e7.3 Materials and Methods 163\u003c\/p\u003e \u003cp\u003e7.3.1 Data Set and Data Pre-Processing 163\u003c\/p\u003e \u003cp\u003e7.3.2 Proposed Model 165\u003c\/p\u003e \u003cp\u003e7.4 Experiment and Result 171\u003c\/p\u003e \u003cp\u003e7.4.1 Experiment Setup 171\u003c\/p\u003e \u003cp\u003e7.4.2 Comparison with Other Models 173\u003c\/p\u003e \u003cp\u003e7.5 Results 174\u003c\/p\u003e \u003cp\u003e7.6 Conclusion 175\u003c\/p\u003e \u003cp\u003eReferences 176\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 An Efficient IoT Framework for Patient Monitoring and Predicting Heart Disease Based on Machine Learning Algorithms 179\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eShanthi S., Nidhya R., Uma Perumal and Manish Kumar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 180\u003c\/p\u003e \u003cp\u003e8.2 Literature Survey 182\u003c\/p\u003e \u003cp\u003e8.3 Machine Learning Algorithms 183\u003c\/p\u003e \u003cp\u003e8.4 Problem Statement 184\u003c\/p\u003e \u003cp\u003e8.5 Proposed Work 185\u003c\/p\u003e \u003cp\u003e8.5.1 Data Set Description 185\u003c\/p\u003e \u003cp\u003e8.5.2 Collection of Values Through Sensor Nodes 186\u003c\/p\u003e \u003cp\u003e8.5.3 Storage of Data in Cloud 187\u003c\/p\u003e \u003cp\u003e8.5.4 Prediction with Machine Learning Algorithms 188\u003c\/p\u003e \u003cp\u003e8.5.4.1 Data Cleaning and Preparation 188\u003c\/p\u003e \u003cp\u003e8.5.4.2 Data Splitting 189\u003c\/p\u003e \u003cp\u003e8.5.4.3 Training and Testing 189\u003c\/p\u003e \u003cp\u003e8.5.5 Machine Learning Algorithms 189\u003c\/p\u003e \u003cp\u003e8.5.5.1 Naive Bayes Algorithm 189\u003c\/p\u003e \u003cp\u003e8.5.5.2 Decision Tree Algorithm 190\u003c\/p\u003e \u003cp\u003e8.5.5.3 K-Neighbors Classifier 191\u003c\/p\u003e \u003cp\u003e8.5.5.4 Logistic Regression 192\u003c\/p\u003e \u003cp\u003e8.6 Performance Analysis and Evaluation 192\u003c\/p\u003e \u003cp\u003e8.7 Conclusion 197\u003c\/p\u003e \u003cp\u003eReferences 197\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 BABW: Biometric-Based Authentication Using DWT and FFNN 201\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eR. Kingsy Grace, M.S. Geetha Devasena and R. Manimegalai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 202\u003c\/p\u003e \u003cp\u003e9.2 Literature Survey 203\u003c\/p\u003e \u003cp\u003e9.3 BABW: Biometric Authentication Using Brain Waves 208\u003c\/p\u003e \u003cp\u003e9.4 Results and Discussion 211\u003c\/p\u003e \u003cp\u003e9.5 Conclusion 215\u003c\/p\u003e \u003cp\u003eReferences 216\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Autism Screening Tools With Machine Learning and Deep Learning Methods: A Review 221\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePavithra D., Jayanthi A. N., Nidhya R. and Balamurugan S.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 222\u003c\/p\u003e \u003cp\u003e10.2 Autism Screening Methods 223\u003c\/p\u003e \u003cp\u003e10.2.1 Autism Screening Instrument for Educational Planning—3rd Version 224\u003c\/p\u003e \u003cp\u003e10.2.2 Quantitative Checklist for Autism in Toddlers 224\u003c\/p\u003e \u003cp\u003e10.2.3 Autism Behavior Checklist 224\u003c\/p\u003e \u003cp\u003e10.2.4 Developmental Behavior Checklist-Early Screen 225\u003c\/p\u003e \u003cp\u003e10.2.5 Childhood Autism Rating Scale Version 2 225\u003c\/p\u003e \u003cp\u003e10.2.6 Autism Spectrum Screening Questionnaire (ASSQ) 226\u003c\/p\u003e \u003cp\u003e10.2.7 Early Screening for Autistic Traits 226\u003c\/p\u003e \u003cp\u003e10.2.8 Autism Spectrum Quotient 226\u003c\/p\u003e \u003cp\u003e10.2.9 Social Communication Questionnaire 227\u003c\/p\u003e \u003cp\u003e10.2.10 Child Behavior Check List 227\u003c\/p\u003e \u003cp\u003e10.2.11 Indian Scale for Assessment of Autism 227\u003c\/p\u003e \u003cp\u003e10.3 Machine Learning in ASD Screening and Diagnosis 228\u003c\/p\u003e \u003cp\u003e10.4 DL in ASD Diagnosis 238\u003c\/p\u003e \u003cp\u003e10.5 Conclusion 242\u003c\/p\u003e \u003cp\u003eReferences 242\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Drug Target Module Mining Using Biological Multifunctional Score-Based Coclustering 249\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eR. Gowri and R. Rathipriya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 249\u003c\/p\u003e \u003cp\u003e11.2 Literature Study 250\u003c\/p\u003e \u003cp\u003e11.3 Materials and Methods 253\u003c\/p\u003e \u003cp\u003e11.3.1 Biological Terminologies 253\u003c\/p\u003e \u003cp\u003e11.3.2 Functional Coherence 256\u003c\/p\u003e \u003cp\u003e11.3.3 Biological Significances 257\u003c\/p\u003e \u003cp\u003e11.3.4 Existing Approach: MR-CoC 257\u003c\/p\u003e \u003cp\u003e11.4 Proposed Approach: MR-CoCmulti 258\u003c\/p\u003e \u003cp\u003e11.4.1 Biological Score Measures for DTM 259\u003c\/p\u003e \u003cp\u003e11.4.2 Multifunctional Score-Based Co-Clustering Approach 259\u003c\/p\u003e \u003cp\u003e11.5 Experimental Analysis 264\u003c\/p\u003e \u003cp\u003e11.5.1 Experimental Results 265\u003c\/p\u003e \u003cp\u003e11.6 Discussion 280\u003c\/p\u003e \u003cp\u003e11.7 Conclusion 280\u003c\/p\u003e \u003cp\u003eAcknowledgment 281\u003c\/p\u003e \u003cp\u003eReferences 281\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 The Ascendant Role of Machine Learning Algorithms in the Prediction of Breast Cancer and Treatment Using Telehealth 285\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJothi K.R., Oswalt Manoj S., Ananya Singhal and Suruchi Parashar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 286\u003c\/p\u003e \u003cp\u003e12.1.1 Objective 287\u003c\/p\u003e \u003cp\u003e12.1.2 Description and Goals 287\u003c\/p\u003e \u003cp\u003e12.1.2.1 Data Exploration 288\u003c\/p\u003e \u003cp\u003e12.1.2.2 Data Pre-Processing 288\u003c\/p\u003e \u003cp\u003e12.1.2.3 Feature Scaling 288\u003c\/p\u003e \u003cp\u003e12.1.2.4 Model Selection and Evaluation 288\u003c\/p\u003e \u003cp\u003e12.2 Literature Review 289\u003c\/p\u003e \u003cp\u003e12.3 Architecture Design and Implementation 304\u003c\/p\u003e \u003cp\u003e12.4 Results and Discussion 310\u003c\/p\u003e \u003cp\u003e12.5 Conclusion 312\u003c\/p\u003e \u003cp\u003e12.6 Future Work 313\u003c\/p\u003e \u003cp\u003eReferences 314\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Remote Patient Monitoring: Data Sharing and Prediction Using Machine Learning 317\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMohammed Hameed Alhameed, S. Shanthi, Uma Perumal and Fathe Jeribi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Introduction 318\u003c\/p\u003e \u003cp\u003e13.1.1 Patient Monitoring in Healthcare System 318\u003c\/p\u003e \u003cp\u003e13.2 Literature Survey 321\u003c\/p\u003e \u003cp\u003e13.3 Problem Statement 322\u003c\/p\u003e \u003cp\u003e13.4 Machine Learning 322\u003c\/p\u003e \u003cp\u003e13.4.1 Introduction 322\u003c\/p\u003e \u003cp\u003e13.4.2 Cloud Computing 324\u003c\/p\u003e \u003cp\u003e13.4.3 Design and Architecture 325\u003c\/p\u003e \u003cp\u003e13.5 Proposed System 326\u003c\/p\u003e \u003cp\u003e13.6 Results and Discussions 331\u003c\/p\u003e \u003cp\u003e13.7 Privacy and Security Challenges 333\u003c\/p\u003e \u003cp\u003e13.8 Conclusions and Future Enhancement 334\u003c\/p\u003e \u003cp\u003eReferences 335\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Investigations on Machine Learning Models to Envisage Coronavirus in Patients 339\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eR. Sabitha, J. Shanthini, R.M. Bhavadharini and S. Karthik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 340\u003c\/p\u003e \u003cp\u003e14.2 Categories of ML Algorithms in Healthcare 341\u003c\/p\u003e \u003cp\u003e14.3 Why ML to Fight COVID-19? Tools and Techniques 343\u003c\/p\u003e \u003cp\u003e14.4 Highlights of ML Algorithms Under Consideration 344\u003c\/p\u003e \u003cp\u003e14.5 Experimentation and Investigation 349\u003c\/p\u003e \u003cp\u003e14.6 Comparative Analysis of the Algorithms 353\u003c\/p\u003e \u003cp\u003e14.7 Scope of Enhancement for Better Investigation 354\u003c\/p\u003e \u003cp\u003eReferences 356\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Healthcare Informatics: Emerging Trends, Challenges, and Analysis of Medical Imaging 359\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eG. Karthick and N.S. Nithya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Emerging Trends and Challenges in Healthcare Informatics 360\u003c\/p\u003e \u003cp\u003e15.1.1 Advanced Technologies in Healthcare Informatics 360\u003c\/p\u003e \u003cp\u003e15.1.2 Intelligent Smart Healthcare Devices Using IoT With DL 361\u003c\/p\u003e \u003cp\u003e15.1.3 Cyber Security in Healthcare Informatics 362\u003c\/p\u003e \u003cp\u003e15.1.4 Trends, Challenges, and Issues in Healthcare IT Analytics 363\u003c\/p\u003e \u003cp\u003e15.2 Performance Analysis of Medical Image Compression Using Wavelet Functions 364\u003c\/p\u003e \u003cp\u003e15.2.1 Introduction 364\u003c\/p\u003e \u003cp\u003e15.2.2 Materials and Methods 366\u003c\/p\u003e \u003cp\u003e15.2.3 Wavelet Basis Functions 367\u003c\/p\u003e \u003cp\u003e15.2.3.1 Haar Wavelet 367\u003c\/p\u003e \u003cp\u003e15.2.3.2 db Wavelet 368\u003c\/p\u003e \u003cp\u003e15.2.3.3 bior Wavelet 368\u003c\/p\u003e \u003cp\u003e15.2.3.4 rbio Wavelet 368\u003c\/p\u003e \u003cp\u003e15.2.3.5 Symlets Wavelet 369\u003c\/p\u003e \u003cp\u003e15.2.3.6 coif Wavelet 369\u003c\/p\u003e \u003cp\u003e15.2.3.7 dmey Wavelet 369\u003c\/p\u003e \u003cp\u003e15.2.3.8 fk Wavelet 369\u003c\/p\u003e \u003cp\u003e15.2.4 Compression Methods 370\u003c\/p\u003e \u003cp\u003e15.2.4.1 Embedded Zero-Trees of Wavelet Transform 370\u003c\/p\u003e \u003cp\u003e15.2.4.2 Set Partitioning in Hierarchical Trees 370\u003c\/p\u003e \u003cp\u003e15.2.4.3 Adaptively Scanned Wavelet Difference Reduction 370\u003c\/p\u003e \u003cp\u003e15.2.4.4 Coefficient Thresholding 371\u003c\/p\u003e \u003cp\u003e15.3 Results and Discussion 371\u003c\/p\u003e \u003cp\u003e15.3.1 Mean Square Error 371\u003c\/p\u003e \u003cp\u003e15.3.2 Peak Signal to Noise Ratio 371\u003c\/p\u003e \u003cp\u003e15.4 Conclusion 380\u003c\/p\u003e \u003cp\u003e15.4.1 Summary 380\u003c\/p\u003e \u003cp\u003eReferences 380\u003c\/p\u003e \u003cp\u003eIndex 383\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":48866419704151,"sku":"9781119841760","price":153.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119841760.jpg?v=1722278556"},{"product_id":"the-precipice-a-book-that-seems-made-for-the-present-moment-new-yorker-9781526600233","title":"The Precipice: ‘A book that seems made for the","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eWhat existential threats does humanity face? And how can we secure our future?\u003c\/b\u003e \u003cb\u003e ‘\u003c\/b\u003e\u003cb\u003e\u003ci\u003eThe Precipice \u003c\/i\u003eis a powerful book . . . Ord’s love for humanity and hope for its future is infectious\u003c\/b\u003e\u003cb\u003e’ \u003c\/b\u003e\u003ci\u003eSpectator\u003c\/i\u003e\u003cb\u003e ‘Ord’s analysis of the science is exemplary . . . Thrillingly written’ \u003c\/b\u003e\u003ci\u003eSunday Times\u003c\/i\u003e  We live during the most important era of human history. In the twentieth century, we developed the means to destroy ourselves – without developing the moral framework to ensure we won't. This is \u003cb\u003ethe Precipice\u003c\/b\u003e, and how we respond to it will be the most crucial decision of our time.  Oxford moral philosopher Toby Ord explores the risks to humanity's future, from the familiar man-made threats of climate change and nuclear war, to the potentially greater, more unfamiliar threats from engineered pandemics and advanced artificial intelligence.  With clear and rigorous thinking, Ord calculates the various risk levels, and shows how our own time fits within the larger story of human history. We can say with certainty that the novel coronavirus does not pose such a risk. But could the next pandemic? And what can we do, in our present moment, to face the risks head on?  A major work that brings together the disciplines of physics, biology, earth and computer science, history, anthropology, statistics, international relations, political science and moral philosophy, \u003ci\u003eThe Precipice \u003c\/i\u003eis a call for a new understanding of our age: a major reorientation in the way we see the world, our history, and the role we play in it.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eToby Ord is today’s Carl Sagan. Clear and inspiring, this book leaves us hopeful for a flourishing human future -- Christine Peterson, co-founder of the Foresight Institute\u003cbr\u003eA powerfully argued book that alerts us to what is perhaps the most important – and yet also most neglected – problem we will ever face -- Peter Singer, author of 'Animal Liberation' and 'The Life You Can Save'\u003cbr\u003e\u003ci\u003eThe Precipice\u003c\/i\u003e separates science from hype and will remain the definitive work on existential risk for a long time to come -- Max Tegmark, author of 'Life 3.0' and 'Our Mathematical Universe'\u003cbr\u003eA fascinating and persuasive guide to the most important topic of all: how our species will survive the risks we pose to our continued existence -- Stuart Russell, author of 'Human Compatible' and 'Artificial Intelligence: A Modern Approach'\u003cbr\u003eThis book is a wake-up call to the existential threats of nuclear and biological weapons and the urgent need for action. A must-read that galvanises us to play a role in addressing these risks -- Angela Kane, former UN High Representative for Disarmament Affairs\u003cbr\u003eHumanity has never been more vulnerable – there’s now a one-in-six chance that civilisation won’t make it to the end of the century, argues a highly influential philosopher . . . Ord’s analysis of the science is exemplary . . . Thrillingly written * Sunday Times *\u003cbr\u003eMany people have recently found that they want to read books offering the grandest perspectives possible on human existence, such as \u003ci\u003eSapiens\u003c\/i\u003e . . . Toby Ord’s new book is a startling and rigorous contribution to this genre that deserves to be just as widely read * Evening Standard *\u003cbr\u003eSplendid . . . \u003ci\u003eThe Precipice \u003c\/i\u003eis a powerful book, written with a philosopher’s eye . . . Ord’s love for humanity and hope for its future is infectious * Spectator *\u003cbr\u003eUrgent and vaguely prophetic . . . In a year in which our everyday lives were upended by the unexpected (or rather the expected yet neglected), \u003ci\u003eThe Precipice \u003c\/i\u003eis a good way to put everything in perspective -- Books of the Year * WIRED *\u003cbr\u003e\u003ci\u003eThe Precipice\u003c\/i\u003e is a fascinating book, one that showcases both the knowledge of its author and his humanity * Axios *\u003cbr\u003eA book that seems made for the present moment * New Yorker *\u003cbr\u003eA story of the greatest risks to humanity’s future, from the climate crisis and nuclear war to pandemics and artificial intelligence -- Highlights for 2020 * Guardian *","brand":"Bloomsbury Publishing PLC","offers":[{"title":"Default Title","offer_id":48867472245079,"sku":"9781526600233","price":12.34,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781526600233.jpg?v=1722283439"},{"product_id":"molecular-biotechnology-principles-and-applications-of-recombinant-dna-9781683673644","title":"Molecular Biotechnology: Principles and","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e","brand":"American Society for Microbiology","offers":[{"title":"Default Title","offer_id":48868060168535,"sku":"9781683673644","price":999.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781683673644.jpg?v=1722286216"},{"product_id":"science-in-the-private-interest-has-the-lure-of-profits-corrupted-biomedical-research-9780742543713","title":"Science in the Private Interest Has the Lure of","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eUniversity science is now entangled with entrepreneurship, and researchers with a commercial interest are caught in an ethical quandary. Science in the Private Interest investigates the trends and effects of modern, commercialized academic science.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003eIn Science in the Private Interest, a strongly argued polemic against the commercial conditions in which scientific research currently operates, [Krimsky] shows how universities have become little more than instruments of wealth. * The New York Review Of Books *\u003cbr\u003eIn Science in the Private Interest, Dr. Krimsky documents the growing entanglement between commerce and academic science. He argues that the lure of profits is transforming universities so that they are no longer independent, disinterested centers of learning that the public has long depended on. * The New York Times *\u003cbr\u003eA must-read for anyone interested in the future of science. * USA Today *\u003cbr\u003eThis is an important and detailed analysis of the transformations of the biomedical sciences as they have become part of a new biomedical-industrial-complex. . . . A timely and much-needed study. -- Everett Mendelsohn, professor of history and science, Harvard University\u003cbr\u003eThis book should be read by anyone concerned about the integrity of knowledge production in a knowledge-based society. Krimsky provides a spirited and engaging defense of academic freedom and sounds a compelling warning of the long-term dangers to society when universities adopt the values of business. -- Mildred Cho, Stanford University\u003cbr\u003eScience in the Private Interest is required reading for all scientists interested in the integrity of researchers and universities. -- Adil E. Shamoo, University of Maryland School of Medicine\u003cbr\u003eSheldon Krimsky is one of the country's leading thinkers about the social and political context of science. This very accessible book offers a powerful insight into how corporate connections are harming the progress of science, tainting free inquiry in our universities, and harming our health. -- Phil Brown, Brown University\u003cbr\u003eReading Krimsky will give those inside and outside the university and college worlds a gripping sense of how large are the stakes and how glorious can be the benefits of defending and expanding the independence of the university from the growing corporate state. . . . A searching and honest book. -- Ralph Nader, from the foreword\u003cbr\u003eScience in the Private Interest makes a timely and welcome contribution. A major strength of Krimsky's book is its comprehensive account of problems that have arisen from the 'partnership' of academia and industry. * Nature Neuroscience *\u003cbr\u003eScience in the Private Interest is carefully researched and presents arguments from all sides of the issues under discussion. Case studies sprinkled throughout the book demonstrate that the main characters—universities, large companies, and some academicians—at times cloak monetary and career-advancing priorities in scientific clothing. Yet most of the pages of the the book are not exposés of biomedical wrongdoing but explanations of the laws and regulations that govern how academia and industry interrelate. * The New England Journal Of Medicine *\u003cbr\u003eKrimsky is certainly not the first to take on conflicts in the scientific world, but his scholarship provides the data that many advocates use in making their case. Even defenders of the commercial ties, who say they speed products to the market and appropriately reward researchers for their work, recognize the importance of Krimsky's data. * The Boston Globe *\u003cbr\u003eBy using thorough analysis, interviews, and careful evaluation of recent patterns, Krimsky attempts to untangle the complex relationship between biomedical research and profiteering, one of the most important issues of our time. * Public Citizen News *\u003cbr\u003eProvides a useful and readable compendium of events and ideas that are familiar to scholars of conflict-of-interest in science. * Nature *\u003cbr\u003eKrimsky has long been a critic of business links to universities. Science in the Private Interest integrates his work and that of others, arguing that the link between universities and business actually presents a serious threat to both universities and society. * Health Affairs *\u003cbr\u003eKrimsky's analysis is informed and his argument well written. Science in the Private Interest is a disturbing book but one that deserves a broad readership. * Science and Theology News *\u003cbr\u003eAlthough this thesis is not new, readers will learn from the detail [Krimsky] presents and from his juxtaposition of a broad range of examples. Bringing together a wealth of evidence from investigative journalism, government reports, and peer-reviewed articles, Krimsky shows that these conflicts of interest are not isolated incidents but form a widespread, increasing pattern. * Nature Medicine *\u003cbr\u003eShrewd, unsparing, and never shrill, this book ought to be obligatory reading for anyone who values the role that science plays in the political life of the United States. With a scholar's care and an idealist's unswerving allegiance to unfettered scientific inquiry, Krimsky explores the true public cost of the transformation of university-based research into a tool of commercial self-interest. * American Scientist *\u003cbr\u003eThe message of this book is relevant to most of us. Because this subject is important, and because Krimsky's writing is clear, there is little to criticize. This vision of what academia has been and what it could continue to be is reason enough to read what Krimsky has to say. * JAMA: The Journal of the American Medical Association *\u003cbr\u003eA must-read for UK science minister Lord Sainsbury. * Ecologist *\u003cbr\u003eKrimsky has written an important and provocative book. Science in the Private Interest should generate fruitful debate about systematic responses to the dangers of research commercialization in the life sciences. * Academe *\u003cbr\u003eI know of no better account of the profound issues regarding the interface between the academic mission and the industrial world than that given by Krimsky. * The Quarterly Review Of Biology *\u003cbr\u003eIn lucid, well-documented discussions, liberally enhanced by appropriate case studies, Sheldon Krimsky shows us how bias and conflict of interest may arise in various forms. * New Jersey Medicine *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePart 1 Foreword Chapter 2 Introduction Chapter 3 Stories of the Unholy Alliance Chapter 4 University-Industry Collaborations Chapter 5 Knowledge as Property Chapter 6 The Changing Ethos of Science Chapter 7 The Redemption of Federal Advisory Committees Chapter 8 Professors Incorporated Chapter 9 Conflicts of Interest Chapter 10 A Question of Bias Chapter 11 The Scientific Journals Chapter 12 The Demise of Public Science Chapter 13 Prospects for a New Moral Sensibility in Academia Chapter 14 Conclusion: Reinvesting in Public Interest Science","brand":"Rowman \u0026 Littlefield","offers":[{"title":"Default Title","offer_id":48884328563031,"sku":"9780742543713","price":43.98,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780742543713.jpg?v=1722531466"},{"product_id":"asian-biotech-9780822347934","title":"Asian Biotech","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eEthnographic analyses of emerging bioscientific enterprises in Asia, including genetically modified foods in China, clinical trials in India, and stem-cell research in Singapore, South Korea, and Taiwan.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e“\u003ci\u003eAsian Biotech\u003c\/i\u003e is a thoughtful examination of Asia’s biotechnology development. The call to understand this realm in terms of situated ethics and communities of fate is persuasive and invites the analysis of more cases to test the robustness of these concepts.” - Wen-Hua Kuo, \u003ci\u003eThe China Quarterly\u003c\/i\u003e\u003cbr\u003e“[W]hat bioethicists could learn from anthropological investigations like those presented in this volume is that one should consider the social and cultural contexts in which the practice to be ethically assessed is embedded in order to understand the the practice more thoroughly. And it is this more thorough understanding which will lead to a more nuanced and better refined ethical judgment.” - Soraj Hongladarom, \u003ci\u003eGenomics, Society, and Policy\u003c\/i\u003e\u003cbr\u003e“I for one would strongly recommend this interesting volume to anyone interested in gaining a better understanding of biotech in Asia.” - Krishna Ravi Srinivas, \u003ci\u003eAsian Biotech and Development Review\u003c\/i\u003e\u003cbr\u003e“[T]his book performs coverage of a region and a complicated sector of the twenty-frst-century economy, and it will certainly prove useful to those interested in globalized medicine and the fast-changing norms regulating research in biomedicine.” - Thomas Cannavino, \u003ci\u003eCultural Critique\u003c\/i\u003e\u003cbr\u003e“This timely and important collection by science-studies scholars provides fascinating glimpses into the ambitious efforts of several Asian countries to deploy biotechnologies to both generate economic growth and provide biosecurity in this age of global science and technology.” - Doogab Yi, \u003ci\u003eChemical Heritage\u003c\/i\u003e\u003cbr\u003e“The need in science studies and anthropology for \u003ci\u003eAsian Biotech\u003c\/i\u003e would be hard to overstate. I was hungry for this book to use in my own teaching and writing, and the meal is as satisfying as I had anticipated. The theoretical framing is astute and generative, and the well-argued and diverse essays are thoroughly fleshed out historically and ethnographically. Nancy N. Chen, Aihwa Ong, and the contributors deserve our thanks. We have just run out of excuses for ongoing Western parochialism in science and technology studies and all of our kindred inquiries into biotechnology.”—\u003cb\u003eDonna Haraway\u003c\/b\u003e, author of \u003ci\u003eWhen Species Meet\u003c\/i\u003e\u003cbr\u003e“This exciting collection of ethnographic essays introduces readers to the deployment of specific biotechnologies in Asia, revealing their enmeshment with local and global politics and a situated ethics that extends to the good of families, communities, and nations, and not merely that of individuals. This book, harbinger of impending futures, demands introspection.”—\u003cb\u003eMargaret Lock\u003c\/b\u003e, author of \u003ci\u003eTwice Dead: Organ Transplants and the Reinvention of Death \u003c\/i\u003e\u003cbr\u003e”This is the first broad anthropological examination of the biotech movement across Asia. Especially useful are the efforts at understanding how biotechnology affects (and is affected by) major changes in moral experience and ethical imagination that are roiling Asian modernities. A pathbreaking exploration! This collection will be influential.”—\u003cb\u003eArthur Kleinman\u003c\/b\u003e, Director, Asia Center, Harvard University\u003cbr\u003e“\u003ci\u003eAsian Biotech\u003c\/i\u003e is a thoughtful examination of Asia’s biotechnology development. The call to understand this realm in terms of situated ethics and communities of fate is persuasive and invites the analysis of more cases to test the robustness of these concepts.” -- Wen-Hua Kuo * The China Quarterly *\u003cbr\u003e“[T]his book performs coverage of a region and a complicated sector of the twenty-frst-century economy, and it will certainly prove useful to those interested in globalized medicine and the fast-changing norms regulating research in biomedicine.” -- Thomas Cannavino * Cultural Critique *\u003cbr\u003e“What bioethicists could learn from anthropological investigations like those presented in this volume is that one should consider the social and cultural contexts in which the practice to be ethically assessed is embedded in order to understand the the practice more thoroughly. And it is this more thorough understanding which will lead to a more nuanced and better refined ethical judgment.” -- Soraj Hongladarom * Genomics, Society and Policy *\u003cbr\u003e“I for one would strongly recommend this interesting volume to anyone interested in gaining a better understanding of biotech in Asia.” -- Krishna Ravi Srinivas * Asian Biotech and Development Review *\u003cbr\u003e“This timely and important collection by science-studies scholars provides fascinating glimpses into the ambitious efforts of several Asian countries to deploy biotechnologies to both generate economic growth and provide biosecurity in this age of global science and technology.” -- Doogab Yi * Chemical Heritage *\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eAcknowledgments \u003cbr\u003e Introduction: An Analytics of Ethics and Biotechnology at Multiple Scales \/ Aihwa Ong 1\u003cbr\u003e Part I. Excess and Opportunity \u003cbr\u003e The Experimental Machinery of Global Clinical Trials: Case Studies from India \/ Kaushik Sunder Rajan 55\u003cbr\u003e Feeding the Nation: Chinese Biotechnology and Genetically Modified Foods \/ Nancy N. Chen 81\u003cbr\u003e Part II. Bioventures \u003cbr\u003e Asian Regeneration? Nationalism and Internationalism in Stem Cell Research in South Korea and Singapore \/ Charis Thompson 95\u003cbr\u003e Medical Tourism in Thailand \/ Ara Wilson 118\u003cbr\u003e Near-Liberalism: Global Corporate Citizenship and Pharmaceutical Marketing in India \/ Stefan Ecks 144\u003cbr\u003e Part III. Communities of Fate \u003cbr\u003e Governing through Blood: Biology, Donation, and Exchange in Urban China \/ Vincanne Adams, Kathleen Erwin, and Phouc V. Le 167\u003cbr\u003e Lifelines: The Ethics of Blood Banking for Family and Beyond \/ Aihwa Ong 190\u003cbr\u003e Embryo Controversies and Governing Stem Cell Research in Japan: How to Regulate Regenerative Futures \/ Margaret Sleeboom-Faulkner 215\u003cbr\u003e Part IV. Biosovereignty: Mappings of Chineseness \u003cbr\u003e Making Taiwanese (Stem Cells): Identity, Genetics, and Hybridity \/ Jennifer A. Liu 239\u003cbr\u003e Chinese DNA: Genomics and Bionations \/ Wen-ching Sung 263\u003cbr\u003e Afterword: Asia's Biotech Bloom \/ Nancy N. Chen 293\u003cbr\u003e Bibliography 301\u003cbr\u003e Contributors 319\u003cbr\u003e Index 323","brand":"Duke University Press","offers":[{"title":"Default Title","offer_id":48884712997207,"sku":"9780822347934","price":110.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780822347934.jpg?v=1722533136"},{"product_id":"imagining-science-9780888645081","title":"Imagining Science","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eArtists, scientists, social commentators engage the thorny issue of biotechnology using a collaborative, positive approach.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\"...The current Art Gallery of Alberta exhibit is a more direct result of a 2007 Banff Centre residency between international artists and scientists. At the center of the residency swirled questions concerning the legal, ethical and social implications in technological advances, and how these issues intersect within the realm between the arts and sciences. ... Increasingly, the strange and the unknown are becoming known, and the limits of how far we go to explore the abyss of knowledge is the shakable foundation of the bioethical dilemma. New York-based Adam Zaretsky explores these limits with the heart of an artist and the soul of a scientist. ... Citing the creation of transgenetic creatures as art, where scientists have to choose a gene to create an organism between the imagination and an objective reality, Zaretsky is transparent about his practice, his concerns, and acknowledges that researchers for the most part have no clear idea of where and how far they are willing to go. 'The things I see in the labs: frogs with eyes coming out of the back of their heads that are connected to the part of the brain that hears instead of sees' he shares within shades of ambivalence and awe. 'Science lives on the edge of knowledge, trying to capture it, torture it until it reveals to us its secrets so that we can claim it. I think these ethical conundrums are worth it. I admit that it's not just a dream, but a nightmare, a real return of the repressed. We're afraid of creative thought leading the way.'\" Amy Fung, Vue Weekly, Nov. 20, 2008.\u003cbr\u003eThis intriguing book is the brainchild of brothers Sean and Timothy Caulfield, both professors at the University of Alberta. From contributors in the worlds of art and science, essays, photographs, paintings and poetry explore the ramifications of bio-technology on the world. Each entry emphasizes the complexity of the topic, stressing how science and art often combine to present a more powerful argument than either could alone. All demonstrate how even microscopic elements in the laboratory impact life and that all of life is connected. Much of this book was part of an exhibit at the University of Alberta art museum. Distributed by Michigan State University Press. Oversize: 11x 10 inches. (Annotation ©2009 Book News Inc. Portland, OR)\u003cbr\u003e\"...Imagining Science [is] an innovative collaboration among scientists, artists, bioethicists and others that investigates numerous contentious bioethical issues, such as stem cell research, genetic testing, patenting of genes and genetic selection of offspring.... In his introductory essay, Timothy Caulfield touches on the controversial social, ethical, legal and religious issues gripping the field of biotechnology and opines that artists are an important voice among the various commentators. Indeed, some artists play the role of provocateur, presenting works inspired by the imagined (or unimaginable) possibilities of biotechnology and some of these works bring the public face-to-face with challenging and troublesome issues in a direct visceral way. The book features the work of 10 artists, along with 18 essays and a poem, all of which aim to shed new light from differing perspectives on biotechnology and the interplay between art and science.... It should appeal to a broad audience of general public as well as professionals (including artists) involved in the biosciences. When you look through it, have Google near at hand since the contributors provide or spin off many juicy references. While reading this book, I spent as much time eagerly surfing as I did looking at the actual pages. Probably a sure sign of a good read in our age.\" Stuart Kinmond, CMAJ, June 23, 2009\u003cbr\u003e\"Imagining Science is an exploration of where and how art and science interact....[It] addresses those expectations and perceptions [of science] with lush photos of evocative art installations and colourful prints beside clear, concise articles on everything from bioethics and genetics to policy and food. Most importantly, however, it brings these disparate groups of artists, scientists, and social commentators together.\" Kathleen Bell, SEE Magazine, July 30, 2009\u003cbr\u003e\"Brothers Tim and Sean Caulfield have collaborated with scientists, artists and social commentators to help everyone see science through art, and come to understand through visual and literary description how art dramatically affects (and is linked to) some of the world's most pressing issues. Their new book...is the first of its kind to explore the ethical questions raised by biotechnology and social progress through art and essays. Through stunning original art and powerful, concise essays, Imagining Science creatively explores such controversial issues such as: stem cell research; creating half human, half beast 'Chimeras'; the influence of art on public policy; ramifications of technology on our environment; synthetic biology; and cloning and genetic testing.... Few books are ever the 'first' to do something truly unique. Imagining Science is one of these few.\" Charmed Magazine: Baltimore Life, Arts \u0026amp; Culture, January 2010 [see full review at http:\/\/www.charmedmag.com\/2610\/book-imaging-science\/]\u003cbr\u003e\"[The editors'] combined expertise guided their excellent selection of contributors to provide a thoughtful and accurate mapping of the larger conversation about bioscience, technology, art, and social concerns.... Imagining Science makes clear that the art\/science interface is becoming a productive field of study with a growing group of its own theorists, critics, curators, and historians. To those already entrenched in the debate, Imagining Science offers a fresh perspective, summarizing the hot topics. For the uninitiated, the collection of words and images is an inviting introduction....It deserves to be read closely and considered carefully. Imagining Science should be a springboard to further exploration of the rich interaction of science with other powerful social forces and institutions.\" JD Talasek, Issues in Science and Technology, Winter 2010 [Full review at http:\/\/www.issues.org\/26.2\/br_talasek.html]\u003cbr\u003e\"[The book] touches on the controversial social, ethical, legal and religious issues gripping the field of biotechnology and states that artists are an important voice among the various commentators. Indeed, artists can play the role of change agent, presenting works inspired by possibilities of biotechnology. The book features the work of 10 artists, along with 18 essays and a poem, all of which aim to bring differing perspectives on biotechnology and the interplay between art and science.\" Canadian BioTechnologist 2.0 [Blog accessed August 10, 2010]\u003cbr\u003e\"Compiled and co-edited by Sean and Timonty Caulfield, Imagining Science is a distinctive collection of informative essays and memorable original artwork by artists, scientists and social commentators from around the world addressing complex and controversial legal, ethical and social concerns about advances in biotechnology ranging from stem cell research, to cloning, to genetic testing. The result is a synthesis of seminal scientific and creative research. Imagining Science is a unique series of collaborations highlighting the functional role art plays in accessibly assessing biomedical technologies and challenging ethical, religious and philosophical boundaries. Thoughtful and thought-provoking, Imagining Science is highly recommended for personal, professional, academic, and community library reference collections and supplemental reading lists.\" Midwest Book Review, September 2009","brand":"University of Alberta Press","offers":[{"title":"Default Title","offer_id":48884961050967,"sku":"9780888645081","price":26.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780888645081.jpg?v=1722534248"},{"product_id":"antennas-and-wireless-power-transfer-methods-for-biomedical-applications-9781119189916","title":"Antennas and Wireless Power Transfer Methods for","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAntennas and Wireless Power Transfer Methods for Biomedical Applications  Join the cutting edge of biomedical technology with this essential reference  The role of wireless communications in biomedical technology is a significant one. Wireless and antenna-driven communication between telemetry components now forms the basis of cardiac pacemakers and defibrillators, cochlear implants, glucose readers, and more. As wireless technology continues to advance and miniaturization progresses, it's more essential than ever that biomedical research and development incorporate the latest technology.  Antennas and Wireless Power Transfer Methods for Biomedical Applications provides a comprehensive introduction to wireless technology and its incorporation into the biomedical field. Beginning with an introduction to recent developments in antenna and wireless technology, it analyzes the major wireless systems currently available and their biomedical applications, actual and potential. The result is","brand":"Wiley","offers":[{"title":"Default Title","offer_id":48885275132247,"sku":"9781119189916","price":76.05,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119189916.jpg?v=1722535682"},{"product_id":"nanoparticles-and-their-conjugates-for-biomedical-applications-an-advanced-material-for-diagnosis-and-therapeutic-treatment-9781536165968","title":"Nanoparticles and their Conjugates for Biomedical","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe rapid developments in nanostructured materials and nanotechnology will have a profound impact in many areas of biomedical applications including delivery of drugs and biomolecules, tissue engineering, detection of biomarkers, cancer diagnosis, cancer therapy, and imaging. This field is expanding fast, and a lot of work is in progress in terms of design, characterisation, synthesis, and application of materials, for controlling shape and size at nanometer scale to develop highly advanced materials for biomedical application and even to design better pharmaceutical products. In recent years, specific attempts have been made to acquire multi-functional nanostructures that could possibly solve the plethora of issues and voids often encountered in both medicinal and biological researches. This book, comprising six chapters, emphasises the practical implementation of few well-known as well as advanced nanostructured materials for the betterment of human health and diagnostic tools. Each chapter emphasises a single aspect of the nanostructures in broader context, providing a brief history, current status, and emerging trends in the same field. In Chapter 1, authors have provided a detailed account of the implementation of nanostructures in the sensing of several key biomolecules, which can detect the well-being of both internal and external structures of the human body. Chapter 2 presents a brief analysis of the current therapeutics focusing on their viability and shortcomings, and addressing the same through the implementation of nanotechnology. Chapter 3 encompasses the challenges in the field of cell-imaging and detection of biomarkers. Authors have provided a vivid explanation regarding the solution of such challenges through designing and functionalisation of several metallic nanoparticles including quantum dots. In Chapter 4, a brief account of the application of nanostructures in the area of tissue engineering and magnetic resonance imaging has been discussed. In Chapter 5, nanomedicines have been introduced by the authors as an advanced diagnostic and therapeutic option as compared to the traditionally available solutions for oral cancer treatment. Finally, Chapter 6 discusses the application of nanotechnology (both organic and inorganic nanoparticles) in restorative dentistry. Also, possible biocompatibility and toxicity of the nanostructures have been discussed so as to streamline the process of selection of suitable tooth implants and oral cleansing techniques.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886150922583,"sku":"9781536165968","price":113.59,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781536165968.jpg?v=1722539000"},{"product_id":"nano-biotechnological-advancements-in-environmental-issues-applications-and-challenges-9781536199758","title":"Nano-Biotechnological Advancements in","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book provides detailed knowledge on different types of pollutants and their hazardous effects on the environment, humans, animals, and plants. It also describes various modern nano-remediation approaches utilizing different nanomaterials for treatment\/management of different wastes, such as nanomaterial-mediated degradation of pharmaceutical and personal care products, nanomaterial-mediated wastewater treatment, nano-biotechnology in solid waste management, nanotechnology in biohydrogen and biodiesel production, and nano-biotechnology in e-waste management. This is an urgent matter for the safety of the environment and for human and animal health.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003ePreface; Nano-Materials in Pharmaceutical and Personal Care Product Degradation in Water; Nanomaterials Mediated Water Treatment; Nanomaterials Mediated Wastewater Treatment; Transgenic Plants in Phytoremediation: A Biotechnological Approach; Nanotechnology in Biodiesel Production; Phycoremediation: A Synergistic Approach for Bioremediation and Biomass Production; Waste Valorization by Composting: Microbial Diversity and Kinetics; Nano Bioremediation Using Gold, Silver, and Copper: An Ecofriendly Approach; Index.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886211805527,"sku":"9781536199758","price":999.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781536199758.jpg?v=1722539225"},{"product_id":"trends-in-bioinformatics-research-9781594547393","title":"Trends in Bioinformatics Research","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe genomic revolution that has spawned microarrays and high throughput technologies has produced vast amounts of complex biological data that require integration and multidimensional analysis. Bioinformatics incorporates sub-disciplines ranging from databases and ontologies to the modelling of complex biological systems by way of molecular evolution and protein structure prediction. This new book provides state-of-the-art research from around the world.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886529098071,"sku":"9781594547393","price":116.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781594547393.jpg?v=1722540472"},{"product_id":"renewable-resources-plant-biotechnology-9781600210037","title":"Renewable Resources \u0026 Plant Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003ePlant biotechnology and renewable resources are the driving forces behind a more sustainable development of agriculture and other related industries in the world. Until the 21st century, the main task for most industries was to raise the volume of production to gain the highest profits possible. Non-renewable natural resources, such as oil, were the most profitable sources of energy. This tendency not only exploited these resources but had harmful side effects: growing environmental pollution and changing the earth into a desert, suitable neither for animals nor human beings. At the beginning of the 21st century, both scientists and \"green movements\" warn that it is necessary to change this philosophy of economic progress towards a more intensive exploration of renewable resources. Biotechnology is one of the very important and novel tools for obtaining diversified materials on the base of renewable resources. They can serve as a source for production of energy, novel materials, fibres, food, agrofine chemicals and composites. It is believed that diversified possibilities for using natural green resources and their processing can ensure balanced progress without side effects on the earth''s environment. This book presents research on the possibilities of creating progress in the processing of renewable resources within the study of biotechnology.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886580871511,"sku":"9781600210037","price":173.24,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781600210037.jpg?v=1722540717"},{"product_id":"biomaterials-research-advances-9781600218927","title":"Biomaterials Research Advances","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eBiomaterials serve as synthetic or natural materials used to replace parts of living systems or to function contact with living tissue. Biomaterials are intended to interface with biological systems to evaluate, treat, augment or replace any tissue, organ or function of the body. A biomaterial is different from a biological material such as bone that is produced by a biological system. Artificial hips, vascular-stents, artificial pacemakers, and catheters are all made from different biomaterials and comprise different medical devices. This book presents new approaches to biomaterial development including multi-field bone remodelling, novel strategies for conferring antibacterial properties to bone cement, polyacrylonitrile-based biomaterials for enzyme immobilisation and functionalised magnetic nanoparticles for tissue engineering from around the globe.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886609969495,"sku":"9781600218927","price":149.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781600218927.jpg?v=1722540853"},{"product_id":"research-progress-in-biotechnology-9781604560008","title":"Research Progress in Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eBiotechnology is a collection of technologies that capitalise on the attributes of cells and biological molecules. Biotechnology will help improve the ability to customise therapies based on individual genomics; prevent, diagnose, and treat all types of diseases rather than rely on rescue therapy and provide breakthroughs in agricultural production and food safety. This book presents the latest research in the field.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886624649559,"sku":"9781604560008","price":149.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781604560008.jpg?v=1722540925"},{"product_id":"biotechnology-state-of-the-art-prospects-for-development-9781604560152","title":"Biotechnology: State of the Art \u0026 Prospects for","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book focuses on biotechnology is a collection of technologies that capitalise on the attributes of cells and biological molecules. Biotechnology will help improve the ability to customise therapies based on individual genomics; prevent, diagnose, and treat all types of diseases rather than rely on rescue therapy and provide breakthroughs in agricultural production and food safety.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886625206615,"sku":"9781604560152","price":149.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781604560152.jpg?v=1722540928"},{"product_id":"biotechnology-research-technology-applications-9781604569018","title":"Biotechnology: Research, Technology \u0026","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eBiotechnology combines disciplines like genetics, molecular biology, biochemistry, embryology and cell biology, which are in turn linked to practical disciplines like chemical engineering, information technology, and robotics. Patho-biotechnology describes the exploitation of pathogens or pathogen derived compounds for beneficial effect. This book presents the latest research in the field.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886654828887,"sku":"9781604569018","price":136.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781604569018.jpg?v=1722541057"},{"product_id":"social-theory-human-biotechnology-9781606925317","title":"Social Theory \u0026 Human Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe book is intended as a contribution towards metatheoretical development as part of the post-postmodern ''return to'' sociological theory associated with Robert Sibeon (1996, 1999, 2004, 2007), Derek Layder (1997, 2004, 2007), Nicos Mouzelis (1991, 1993, 1995, 2007), Margaret Archer (1995, 1998) and Owen [2006a, 2006b, 2007a, 2007b] in tandem with a study of some of the sociological and ethical implications of selected examples of human biotechnology. The examples include the Human Genome Project, and related areas of interest such as reproductive biotechnology; the attempts to develop a biological sociology by writers of the ''embodied'' school; and what Powell and Owen (2005) term ''the biomedical model''. The book is also intended to contribute towards ''building bridges'' between post-modern metatheory and biological science.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886695526743,"sku":"9781606925317","price":73.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781606925317.jpg?v=1722541215"},{"product_id":"industrial-biotechnology-patenting-trends-innovation-9781607410324","title":"Industrial Biotechnology: Patenting Trends \u0026","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book provides a profile of innovation in industrial biotechnology, an emerging field of biotechnology characterised by the use of enzymes, microorganisms, and other biocatalysts to create new processes and products. Industrial biotechnology is used to make biofuels, chemicals and other products in more sustainable and environmentally friendly ways by, for example, enabling the use of renewable resources rather than petroleum-based products, eliminating harmful by-products created by conventional chemical processes, reducing energy requirements and greenhouse gas emissions, and\/or lowering manufacturing costs. Because of these positive attributes, the demand for industrial biotechnology products and processes is increasing. Patent data, survey results, and technology and firm level data is used from emerging sectors of industrial biotechnology to provide a detailed picture of innovation in the field. Furthermore, this book finds substantial evidence that the field of industrial biotechnology is diverse and growing, with new patent owners entering at a steady rate. Different companies, ranging from small to large in size, are dominant in different areas of industrial biotechnology and patent portfolios play an important role in their participation by facilitating the commercialisation of new products and processes.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886715449687,"sku":"9781607410324","price":999.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781607410324.jpg?v=1722541282"},{"product_id":"industrial-biotechnology-the-u-s-chemical-biofuel-industries-industrial-biotechnology-the-u-s-chemical-biofuel-industries-9781607418993","title":"Industrial Biotechnology \u0026 the U.S. Chemical \u0026","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThe Committee on Finance of the United States Senate requested the Commission to examine the competitive conditions affecting certain industries that are developing and adopting new industrial biotechnology (IB) processes and products. IB was defined as the manufacture of liquid fuel and chemical products using enzymes, micro-organisms, or renewable resources. The application of IB can improve the efficiency of the industries and lead to the development of new products. Thus, this book focuses on U.S. liquid biofuel producers and firms in the U.S. chemical industry. An analysis of the current impact of IB on the U.S. economy is also provided. Industrial biotechnology (IB) activities in the U.S. by the chemical and liquid fuel industries increased substantially during the 2004-2007 period. Sales of U.S. produced bio-based products, for example, increased by over 30% during the period. As discussed in this book, much of this growth is accounted for by the ethanol and biodiesel industries, which are strongly supported by government tax incentives or mandatory use regulations, or both.","brand":"Nova Science Publishers Inc","offers":[{"title":"Default Title","offer_id":48886749135191,"sku":"9781607418993","price":73.49,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781607418993.jpg?v=1722541383"}],"url":"https:\/\/bookcurl.com\/collections\/biotechnology.oembed?page=24","provider":"Book Curl","version":"1.0","type":"link"}